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Gold nanoparticles, a class of plasmonic nanoparticle, have increasingly been 
explored as an imaging and therapeutic agent to treat cancer due to their characteristic 
surface plasmon resonance phenomenon and penchant for tumor accumulation. 
Photothermal therapy has been shown as a promising cancer treatment by delivering heat 
specifically to the tumor site via gold nanoparticles. In this study, we demonstrate that 
gold nanorod (GNR)-mediated photothermal therapy can be more effective through the 
understanding of cell death mechanisms. By targeting GNRs to various cellular 
localizations, we explored the association of GNR localization with cell death pathway 
response to photothermal therapy. Furthermore, we compared the 2D monolayer 
experiments with 3D in vitro tumor models, multicellular tumor spheroids (MCTS), to 
mimic the structure of in vivo tumors. With MCTS, we evaluated the cell death response 
with GNRs distributed only on the periphery, as seen in typical in vivo studies, and 
distributed evenly throughout the tumor. 
We demonstrated that GNR localization influences the cell death response to 
photothermal therapy by showing the power threshold necessary to induce significant 
apoptotic and necrotic increases was lower for internalized GNRs than membrane-bound 
 viii 
GNRs. Furthermore, apoptosis was found to increase with increasing laser power until 
the necrotic threshold and decreased above it, as necrosis became the dominant cell death 
pathway response. A similar trend was revealed with the 3D MCTS; however, the overall 
cell death percentages were lower, most likely due to the upregulated cell repair response 
and varied GNR distributions due to the presence of cell-cell and cell-matrix interactions. 
Furthermore, the uniformly distributed GNRs induced more apoptosis and necrosis than 
GNRs located in the MCTS periphery. In conclusion, we quantitatively analyzed the cell 
death pathway response to GNR-mediated photothermal therapy to establish that it has 
some dependence on GNR localization and distribution to gain a more thorough 
understanding of this response for photothermal therapy optimization. 
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Chapter 1:  Introduction 
1.1 MOTIVATION 
Scientists and physicians have long sought a cure for cancer, the second leading 
cause of death in the United States. This goal remains elusive despite decades of 
oncological research. In this study, our focus is on colon cancer, which has a low survival 
rate. It has been recently estimated that 142,820 men and women will be diagnosed with 
colorectal cancer in the year 2013 alone; 50,830 of which will die of the disease (1). The 
volatility and unpredictability of cancer contributes to the difficulty in treating the disease 
effectively. Furthermore, all current techniques have potentially devastating side effects. 
The most prevalent approved methods of treating cancer - chemotherapy, radiation, and 
surgery - have not improved cancer survival rates significantly over the past 10 years due 
to their limitations in convenience and effectiveness (2). Both chemotherapy and 
radiation therapy target all highly proliferating cells within the body affecting not only 
cancer cells but also cells in hair follicles, gastrointestinal epithelium, and immune 
system. Radiation therapy is considerably more localized; however, chemotherapy is 
systemic and affects the whole body (3-5). As such, there is a great need for a therapeutic 
technique that can be utilized for many different types of cancer without causing 
significant side effects. The need for a minimally invasive, non-surgical, method of 
cancer therapy is currently a widely researched topic. Fortunately, this has increased the 
emphasis on developing more targeted and patient compliant treatments, such as gold 
nanoparticle-mediated photothermal therapy. 
Thermal therapy, induced hyperthermia, has shown potential for the non-invasive 
treatment of cancer. Current hyperthermia-based procedures, including microwave and 
radio frequency heating, use elevated temperatures (ranging from 40-47° C) to ablate 
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diseased tissue, such as cancerous tumors (6, 7).  Hyperthermia elicits cell death, induces 
thermotolerance, alters signal transduction pathways and sensitizes the tumor cells to 
other therapeutics such as radiation and chemotherapy. The thermal effect is more 
effective in cancers because they have a lower thermotolerance than noncancerous tissue 
due to their poor blood supply, thus, are more susceptible to heating (8, 9).  Thermal 
therapy provides broad heating to the tissue making it difficult to localize for targeting a 
specific tumor site, resulting in undesired collateral damage.   
Recently, photothermal therapy has been explored as an effective method of 
utilizing heat to treat cancer.  Differing from conventional thermal therapy, photothermal 
therapy provides localized “hot spots” within the tumor at much higher temperatures on 
the surface of the exogenous agents, which can be targeted specifically to diseased tissue 
limiting collateral damage.  The most common exogenous agent utilized for photothermal 
therapy is the gold nanoparticle (GNP).  Studies have demonstrated that GNPs are 
extremely effective photothermal agents, converting light radiation into thermal energy at 
a high efficiency, and a successful cancer therapeutic in vitro and in vivo due to their 
passive and active targeting abilities (10-16). However, the cell death mechanisms in 
response to photothermal therapy are not well understood. 
1.2 PROBLEM STATEMENT 
The goal of this thesis is to obtain a greater understanding of the cellular response 
to the localized photothermal heating from the irradiated gold nanorods (GNRs). This 
understanding is necessary for the optimization of photothermal therapy to increase its 
effectiveness as a cancer treatment. Our objectives include: (1) determining the 
photothermal therapy dependence on GNR localization and then (2) determining the cell 
death pathway response to GNR localization and differing photothermal parameters. F, 
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we determine the photothermal thresholds for (1) initiating the apoptotic cascade and (2) 
when necrosis becomes the dominant cell death pathway. To better understand this 
process, we explore the cell death response due to photothermal therapy in monolayer 
cell cultures and multicellular tumor spheroids (3D cell structures, to mimic in vivo 
tumors). The cell death response to tumor spheroids is compared to the monolayer studies 
to comprehend the differences and similarities. Overall, we aim to show that through the 
quantitative analysis of the cellular death pathway response to GNR-mediated 
photothermal therapy we will be able to optimize and improve cancer therapy. 
1.3 PLASMONIC NANOPARTICLES 
Nanoparticles have risen to prominence in cancer diagnostic and therapeutic 
research due to their atomic size, multifunctionality, and adjustable optical properties. 
They are composed of an assortment of materials fabricated on the nanoscale.  In this size 
range, typical bulk methods to measure the electromagnetic properties do not apply to 
certain materials, including noble metal particles, known as plasmonic nanoparticles.   
Plasmonic nanoparticles have been used extensively for biological imaging and 
detection.  The preferred method of visualizing these plasmonic nanoparticles is through 
optical microscopy, as a result of their absorption and scattering properties. Scattering-
based microscopy techniques, such as differential interference contrast and dark-field 
microscopy, were found to be more common because of their ease of use and availability.  
However, two-photon microscopy, a luminescence-based technique, implements thin 
optical sectioning, which allows for higher resolution three-dimensional images than 
other optical microscopy techniques. Thus, the ideal choice of microscopy technique for 
imaging plasmonic nanoparticles depends on the application and obtainable resources, 
making two-photon microscopy our choice. 
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 Surface plasmon resonance (SPR) is a unique property utilized for the detection 
and imaging of plasmonic nanoparticles, first realized by Gustav Mie in 1908 (17).   
Plasmonic nanoparticles absorb and scatter light regulated by the SPR characteristic 
frequency.  The incident light electric field induces the collective oscillation of the 
conduction electrons on the nanoparticle surface. Consequently, the nanoparticle electric 
field is enhanced and displaced by the collective oscillation of the surface conduction 
electrons allowing for the nanoparticle absorption during the non-radiative decay (18-20).  
Adversely, nanoparticle Rayleigh scattering corresponds specifically to the 
electromagnetic energy emanated by the oscillating electric field (19). 
 The SPR characteristic frequency depends strongly on the physical and 
electromagnetic properties of the plasmonic nanoparticle. Studies have investigated the 
effect on SPR frequency based on metal type, geometry (21-23), inter-nanoparticle 
coupling (24-26), nanoparticle surface functionalization, and the nanoparticle and 
surrounding medium dielectric properties(27, 28). Utilizing these characteristics, the SPR 
frequency can be tuned from the ultraviolet (UV) to the infrared (IR). Typically, 
hemoglobin (absorbing in the visible, ~533 nm), melanin (absorbs in the UV) and water 
(absorbs from the mid-IR to IR) are the most prominent molecular absorbers in the body. 
Thus, between UV and IR wavelengths, the near infrared wavelength (NIR, 600-1000 
nm) range, known as the therapeutic window, is the most desired for biological 
applications because there is less interference, from scattering and absorption (29).  
After excitation, the metal nanoparticle electron relaxation is achieved through the 
non-radiative decay pathway of the plasmon oscillations, leading to two different effects: 
heat and luminescence. The rapid localized heating uniformly heats the nanoparticle 
surroundings. It is a photothermal effect that is proportional to the power of the incident 
light electromagnetic field (21). The luminescence, on the other hand, can be utilized as a 
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contrast mechanism to image plasmonic nanoparticles. The nanoparticle Rayleigh 
scattering is also effective as a contrast mechanism for imaging and determining the 
plasmonic nanoparticle structure. 
The optical properties and peak SPR frequency can be modeled for gold 
nanoparticles using solutions to Maxwell’s equations. The SPR-dependent values, 
including nanoparticle geometry and the dielectric properties of the nanoparticle and 
surrounding media, are necessary to model the nanoparticle effectively. Mie theory is 
widely used as an exact solution to Maxwell’s equations for homogenous concentric 
spheres (17). It has also been expanded to solve for spheres with layered distributions of 
different materials. According to Mie theory, small spherical nanoparticles exhibit only 
one peak plasmon resonance frequency, whereas anisotropic particles exhibit two or more 
peak plasmon bands based on their shape.   
Typically, the discrete dipole approximation (DDA), based on the lattice 
dispersion relation, is used to determine the optical properties and SPR frequency of non-
spherical, anisotropic nanoparticles. DDA models the geometry of the nanoparticle as a 
finite array of polarizable points, which act as dipoles due to the incident electric fields 
(30, 31). Draine and Flatau developed the DDSCAT program to use the DDA to solve for 
the absorption and scattering of electromagnetic waves by targets of arbitrary geometry 
(32). This approximation has been used to study colloids of both gold and silver (33) as 
well as GNRs (34-37). 
1.4 GOLD NANOPARTICLES 
1.4.1 Optical Properties  
GNPs are a class of plasmonic nanoparticles, which exhibit this localized 
enhanced SPR phenomenon, when fabricated on the nanoscale. As discussed, the incident 
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electric field induces collective oscillations of surface conduction electrons on the GNP 
in resonance with the incident electric field (18-20, 22, 38). The SPR characteristic 
frequency depends strongly on the physical properties of the GNP as well as the 
electromagnetic properties of the GNP and the surrounding medium dielectric properties, 
which can be modeled using Mie theory and DDA. 
The resulting values from both Mie theory and DDA are absorption and scattering 
efficiencies for each wavelength modeled. The wavelength that corresponds to the 
maximum absorption efficiency is the peak SPR frequency. When added together for 
each wavelength, the absorption and scattering efficiencies amount to the extinction 
efficiency, the total attenuation by the nanoparticle. The ratio of the absorption and 
scattering efficiency values, respectively, with the total extinction values indicate the 
percentage of light absorbed or scattered at each wavelength. With the scattering and 
absorption efficiency values, determining the optical scattering and absorption cross-
section is straightforward: 
gss Q    
gaa Q    
where the σs and σg are the optical scattering and absorption cross-sections, Qs and Qa are 
the scattering and absorption efficiencies, and σg is the geometric cross-section, which 
can be measured (39). The wavelengths at which nanoparticles strongly scatter or absorb 
are directly based on these results, as we have modeled in this study, which are exploited 
for several different imaging techniques.    
GNPs have been fabricated in many different shapes and sizes. The most basic 
form, gold nanospheres, is a solid, spherical colloid, which can range in size anywhere in 
the nanoscale. Nanospheres tend to absorb light in the visible region of the spectra and 
their peak SPR frequency is relatively untunable. The peak SPR frequency depends on 
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the particle radii but large changes in the radii only slightly influence the frequency (21).  
According to Mie theory, gold nanospheres have a higher absorption component than 
scattering due to their small size, but are still effective in both scattering-based and 
luminescence-based imaging techniques. As the nanosphere size increases, the scattering 
component increases and the absorption component decreases. This trend is seen in all 
geometries of GNPs; therefore, it has been stated that, generally, smaller GNPs (<50 nm) 
are absorption dominant whereas larger GNPs (>50 nm) are scattering dominant (19, 22, 
23). 
 Several groups have fabricated other GNPs with tunable peak SPR frequencies, 
including gold nanoshells. The pioneering work on gold nanoshells was performed by 
research groups from Rice University. The nanoshell SPR frequency is tunable because it 
is composed of a silica core coated with a gold shell (40-42). Adjusting the shell 
thickness to total diameter ratio alters the peak SPR frequency, making it possible to tune 
the frequency into the NIR. These particles are relatively large, with sizes on the order of 
100 nm. Due to their larger size, these nanoparticles have a stronger scattering 
component than absorbing. Even though the scattering component is dominant, the 
absorption cross-section of nanoshells is still much larger than typical fluorescent 
molecules (22, 40). As a modification on traditional nanoshells, one group has also 
fabricated hollow gold nanoshells with a hollow core and a gold shell, which are still 
tunable, but smaller than typical gold nanoshells, on the order of 40-50 nm (43, 44).   
 GNRs are another frequently used tunable particle, composed of solid gold in a 
pill-shape, ranging in size characteristically from 20-50 nm. These nanoparticles are 
smaller than typical nanoshells and, as a result, are absorption dominant, which is 
essential for luminescence-based imaging techniques (45). Even though the scattering is 
dominated by the absorption, the scattering component is strong enough to be imaged by 
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many scattering-based techniques. Due to their pill shape, GNRs have a longitudinal 
(along the length of the GNR) axis and a transverse (along the width of the GNR) axis. 
Accordingly, each axis has a SPR peak frequency, but because of their relative sizes the 
longitudinal axis SPR peak is much stronger than the transverse axis SPR peak (46). By 
increasing the aspect ratio (ratio of the length and width dimension) the SPR peak 
wavelength progresses to longer wavelengths, and can be tuned to the NIR (22, 47, 48). 
At the peak SPR frequency, GNRs have strong absorption and scattering, which has been 
exploited for imaging and photothermal therapy. In this study, we utilized GNRs, due to 
their smaller size for targeting purposes, tunable NIR peak SPR frequency, strong 
contrast in two-photon imaging and high photothermal transduction efficiency (49).   
1.4.2 Gold Nanoparticle Delivery  
Gold is widely used in metal nanoparticle fabrication for biological applications 
because it is inert and biocompatible. In fact, for many years, gold was ingested as an 
anti-inflammatory agent and arthritic treatment (50). GNPs have been observed to 
preferentially accumulate within solid tumors due to their design. The enhanced 
permeability and retention effect (EPR) is a phenomenon found in most solid tumors, 
which maintains that molecules within a certain size range accumulate in the tumor site at 
a higher rate than normal tissue (51-53). Due to the fast-growing nature, tumors outgrow 
the original vascular structure and require more nutrients; therefore, tumors enhance 
proliferation by inducing angiogenesis to increase the flow of nutrients that reach the 
cancer cells. However, the new tumor blood vessels are crudely formed and tend to 
contain fenestrations on the order of 0.5-1.5 µm that form between the endothelial cells 
lining the blood vessel (52-54). GNPs, designed with size dimensions smaller than these 
fenestrations, “leak” through the newly formed tumor blood vessels into the tumor tissue 
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at a much higher rate than normal tissue (55). Furthermore, the lymphatic system 
surrounding the tumors is insufficient and leads to the inability to remove waste. 
Therefore, GNPs, typically on the order of tens to hundreds of nanometers, penetrate 
through the blood vessel enhanced permeability and are retained in the tumor site due to 
the poor lymphatic system (51, 55).  
In addition, the gold surface of GNPs allow for facile bioconjugation of 
antibodies, peptides and polymers through surface modification (56-58). Thus, to 
increase biocompatibility, several different polymers have been conjugated onto the GNP 
surface, with the most common being polyethylene glycol (PEG). PEG has a neutral 
surface charge and prevents adsorption of serum proteins, therefore increasing the 
circulation time in the blood significantly (59-61). Several toxicity studies have been 
performed in vitro and in vivo showing that most GNPs have negligible toxic effects (60, 
62-66); and in fact, recent studies have shown that GNPs are non-toxic for up to 400 days 
(67).  In addition, numerous groups have exploited this facile surface modification to 
conjugate cancer biomarkers onto the GNP surface (68-74). Several cancer biomarkers, 
including anti-EGFR and anti-HER2 antibodies, have been used to successfully actively 
target tumor cells in vitro (70, 75-77). By conjugating antibodies onto GNPs to target 
certain cancer cell types, studies have shown that the incident power necessary to induce 
cell death during photothermal therapy is reduced (14, 43, 70).  
1.5 PHOTOTHERMAL THERAPY 
Thermal therapy has shown potential as a tool for the treatment of solid tumors, 
due to cancerous cells having a low thermotolerance, compared to non-cancerous tissue, 
because of their poor blood supply (8, 9).  Current hyperthermia-based procedures, 
including microwave and radio frequency (RF) heating, use elevated temperatures 
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(ranging from 42-47° C) to damage diseased tissue, such as cancerous tumors (6, 7).  
Both techniques provide a broad heating of the tumor; however, the heating is not 
specific to the tumor, elevating temperatures in surrounding normal tissue.  Accordingly, 
it is desirable to focus the heat to within the tumor periphery.  Due to the small GNP size, 
the emitted heat is confined (on the order of nanometers) to the immediate surroundings 
of the nanoparticle (15). 
Recently, photothermal therapy has been explored as an effective method of 
utilizing heat to treat cancer. Photothermal therapy, a targeted approach of cancer 
hyperthermia therapy, specifically directs heat into the tumor.  In this procedure, an 
endogenous or exogenous chromophore is excited by laser radiation resulting in the 
release of thermal energy. Differing from conventional thermal therapy, photothermal 
therapy provides localized “hot spots” within the tumor at much higher temperatures on 
the surface of the exogenous agents. If the photothermal agent can convert light into heat 
efficiently (photothermal transduction efficiency) then light can be delivered using a laser 
at sub-lethal powers while still inducing heat transfer from the agent to the tumor (49). 
Furthermore, the photothermal agent can be targeted to the tumor site such that the 
elevated temperature is localized to only the tumor immediate surroundings. As a result, 
to be an effective photothermal agent, the exogenous particle is required to be inherently 
inert, can be targeted to a tumor site, can be imaged, and have high photothermal 
transduction efficiency. Studies have demonstrated that GNPs fulfill those requirements 
(10-12, 49, 78, 79). In fact, GNP-mediated photothermal therapy has been extensively 
shown to efficiently kill cancer cells in vitro, by such processes as protein denaturation 
and cellular membrane disruption, and reduce tumor size in vivo (15, 72, 76, 80-84). 
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1.6 TWO-PHOTON MICROSCOPY 
As discussed earlier, GNPs have strong scattering and absorption cross-sections 
that can be exploited as contrast mechanisms for imaging. Scattering-based microscopy 
techniques include bright-field, differential interference contrast, dark-field and 
reflectance confocal microscopy as well as optical coherence tomography. However, by 
utilizing the absorption properties of GNP, it is also possible to visualize the resulting 
luminescence emitted from the GNP, such as using two-photon microscopy. 
A common disadvantage found in all optical microscopy techniques is diffraction-
limited resolution. Diffraction is essentially the bending and spreading of waves, and 
occurs when an electromagnetic wave, such as light, is incident on a circular lens or 
mirror. As a result, the light does not focus to a singular point but rather an Airy disk.  
The Airy disk is observed at the best focused point as a circular spot of light. The 
diameter of the Airy disk and, consequently, the microscope resolution depends directly 




d   
where d is the resolution (and Airy disk diameter), n is the refractive index of medium 
from the objective to the sample, and θ is the angle at which the light is converging. 
Normally, with visible light the ideal resolution is limited to approximately 0.2 µm 
(micron to sub-micron range), therefore these optical techniques are known to be 
microscopic. GNPs are much smaller than this resolution limit; thus, with traditional 
microscopy, it is difficult to resolve them individually. 
 Two-photon microscopy (TPM) is a laser scanning fluorescence imaging 
modality that provides improvements over conventional wide-field and single photon 
fluorescence microscopy. In TPM, the basic idea is that at sufficiently high photon 
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densities, two photons with half the energy difference of an electronic transition – 
exciting fluorescent molecules – can be absorbed simultaneously, in a nonlinear process.   
Since the probability of the two photons to be absorbed simultaneously is quadratically 
dependent on the incident intensity, a femtosecond pulsed laser is used such that enough 
excitation photons are provided to induce two photon absorption. In addition, the two 
photons need to be tightly focused such that the excitation and resulting fluorescence 
generation is limited to an extremely small focal volume, usually accomplished using 
high numerical aperture objectives. This spatial confinement of both two photon 
absorption and subsequent emission results in the property of three-dimensional 
resolvability, owing to the reduction in out-of-focus signal generation and increase in the 
spatial resolution (85). 
Due to the use of longer wavelength light, typically in the NIR (700-1000 nm), 
and the absorption volume being spatially confined to the focal region, TPM is well 
suited for higher depth imaging in optically thick biological samples. TPM generates less 
out-of-focus signal than either wide-field or confocal fluorescence resulting in improved 
sectioning for three-dimensional imaging and limited photobleaching. Typically, the 
resolution spatially and laterally is the same as a perfectly aligned confocal microscope 
without needing a pinhole, allowing for flexibility in detection geometry (85, 86). 
GNPs were found to strongly absorb the two photons simultaneously in a non-
linear process, due to the coupling of the localized SPRs, exciting the nanoparticle 
electrons to a higher energy state, thus, GNPs have a strong two-photon absorption cross-
section.  In the non-radiative relaxation process, these nanoparticles emit an extremely 
strong photoluminescence effect.  One of the first studies utilizing GNPs as a contrast 
agent for TPM imaged gold nanospheres. The authors imaged different sized nanospheres 
(2.5, 15, 60 and 125 nm) under TPM and determined that the 60 nm particles exhibited 
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the strongest emission, whereas the 2.5 nm particles were the weakest by a factor of 3-4. 
The particles were found to be photostable and devoid of “blinking” effects. To illustrate 
that aggregation was artificially enhancing the two-photon emission, the authors used 
DFM to image 15 nm gold nanospheres coated with silica to reduce nanoparticle 
coupling (87). 
One group in particular, Wei, Cheng and coworkers, has pioneered the use of 
GNRs specifically as a contrast agent for TPM. The authors characterized single GNRs 
with TPM by imaging at different excitation wavelengths. They determined that the GNR 
two-photon excitation correlated well with the longitudinal SPR band, and the emission 
was in the 400-650 nm region, nearly 60 times brighter than a fluorescent rhodamine 
molecule. Since GNR absorption is polarization dependent due to its shape, the authors 
also established that the GNRs have a cos
4
 dependence on the excitation polarization 
(88).  
The next studies presented by this group involved the in vitro imaging of GNRs 
using TPM as a method to determine the nanorod localization, similar to studies 
performed in this thesis. In one of their studies, the authors compared the cellular uptake 
of nanorods coated with cetyltrimethylammounium bromide (CTAB) – a typical 
surfactant used in the fabrication of GNRs – and nanorods coated with hydrophilic 
surfactants such as bis(p-sulfonatophenyl) phenylphosphine (BSP) and PEG.  TPM was 
used to visualize the nanorod position and co-localized with phase contrast microscopy to 
visualize the oral epithelium cancer (KB) cells. Using single nanorod tracking, the CTAB 
nanorod uptake kinetics were determined and found to cause no adverse effects on the 
cell within a 5 day period. The CTAB nanorods were internalized at a much higher rate 
than the BSP and PEG nanorods (89). The authors furthered their studies by targeting the 
GNRs to the KB cells using folate conjugated onto the gold surface. TPM images of the 
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folate-conjugated nanorods show that their preferential binding to the cell surface of KB 
cells, which overexpress the folate receptor, compared to the negative control of NIH-
3T3 cells, which do not express the folate receptor (72). 
Intra-vital TPM imaging of surface blood vessels has been accomplished in vivo. 
One study compared the pharmacokinetics of linear PEG and branched PEG 
functionalized GNRs in vivo. Due to the GNR SPR frequency tuned to the NIR, it is 
possible to image deeper in vivo without interference from endogenous sources. In 
addition, the authors utilized TPM to determine the biodistribution of the nanorods in 
explanted organs, using autofluorescence to visualize the cells, from mice (90). 
Several other groups have utilized TPM as a method of visualizing GNPs to 
determine their distribution and localization in vitro. One group imaged hamster ovary 
(CHO) cells, visualized using two photon autofluorescence, targeted by Concanavalin A 
conjugated 10 nm gold nanospheres (91).  Using TPM, another group imaged anti-EGFR 
antibody conjugated nanorods targeted to unstained A431 cells, which were visualized 
using autofluorescence. The authors also characterized the difference in power necessary 
to image at the same signal level: autofluorescence in cells (~9 mW) and the GNRs (140 
µW), showing that the GNRs are ~4000 times brighter (75).    
In our lab, previous studies have used TPM to image the gold nanoshell 
distribution ex vivo, in excised tumors. First, the authors characterized nanoshells (135 
nm in diameter) as an effective contrast agent for TPM. In the study, the authors 
intravenously injected gold nanoshells into the tail veins of tumored mice, with 
subcutaneous colorectal tumors, and excised the tumors to image the distribution of the 
gold nanoshells within the tumor. Intratumoral localization was performed by staining the 
blood vessels (Immunohistochemistry – IHC) and nuclei (YOYO). Three-dimensional 
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imaging was also performed, exploiting the thin optical sectioning capabilities of TPM, to 
illustrate that the nanoshells were found surrounding blood vessels in the tumor (92).   
Our group has also followed up on this study by utilizing TPM to analyze and 
determine the cellular level biodistribution of gold nanoshell and nanorods (41 nm in 
length and 10 nm in width) in tumored mice. The authors excised the tumors with either 
gold nanoshells or nanorods and imaged multiple sections stained with hematoxylin and 
eosin (H&E – a common histopathological stain), YOYO for nuclei, or IHC for blood 
vessels. In addition, the authors imaged H&E stained liver and spleen slices with either 
gold nanoshells or nanorods. Through all of the TPM images, the authors determined that 
the nanoshells and nanorods had a heterogeneous distribution in the tumor with most 
accumulation near the tumor edge and unique patterns close to vasculature. The nanorods 
had a higher accumulation in the tumor core than the nanoshells, possibly due to their 
smaller size. However, in the liver and spleen, based on TPM images, there was a 
significant accumulation of both nanoshells and nanorods with no discernible difference 
between the two particle types (93). 
1.7 CELL DEATH PATHWAYS 
The two primary pathways of cell death investigated in this study are necrosis and 
apoptosis (94, 95). Necrosis is defined as premature injury-related cell death due to 
external factors, whereas apoptosis is programmed cell death initiated by naturally 
causing extrinsic and intrinsic factors. Necrosis typically consists of rounding of the cell 
due to cytoplasmic swelling, as well as the disruption of organelle membranes. 
Subsequently, cell functions completely break down and the plasma membrane ruptures 
resulting in the cytoplasmic contents leaking into the extracellular space, leading to 
inflammation. During the final steps of necrotic cell death, the cells release pro-
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inflammatory factors from the cytoplasm including alarmin molecules, heat-shock 
proteins, histones, and cytokines (96, 97). 
Conversely, apoptosis, a type of programmed cell death, involves a complex 
signaling pathway induced through intracellular signaling, extracellular receptors and the 
mitochondria (94, 95). Apoptosis is a normal part of the cell cycle and is continuously 
induced in thousands of cells within the human body, although, it is inhibited in some 
form in cancer cells to allow for the unregulated growth seen in tumors. It can be 
instigated externally by cytokines through the tumor necrosis factor (TNF) family 
receptors, toxins, hormones, and growth factors. The intrinsic pathways are initiated by 
stress from heat, radiation, nutrient deprivation, hypoxia and viral infection (98).  
The mitochondria are an essential component in the initiation of the apoptotic 
cascade (99, 100). When initiated, the outer mitochondrial membrane permeabilizes and 
releases SMAC (secondary mitochondria-derived activator of caspases), which impedes 
inhibitors of apoptotic proteins, and cytochrome c, which combines with APAF-1 
(apoptotic protease activating factor) and pro-caspase 9 to form the apoptosome. The 
apoptosome then activates (by cleavage) caspase 9, which then activates the effector 
caspases that trigger the apoptotic process by cleaving structural proteins.  
Apoptosis is a caspase-dependent form of programmed cell death leading to 
disassembly of the cell. Caspases are cysteine aspartic proteases involved directly in the 
apoptotic process. Inactive caspases are synthesized with a pro-domain and cleaving this 
pro-domain activates the caspase. The cleaving process is regulated by other proteins, 
death receptors, the apoptosome and other caspases (101-103). Caspases are divided into 
two groups: initiators and effectors (executioners).The initiator caspases, primarily 
caspase 8 and 9 (2 and 10 are less prominent), are activated early in the apoptotic cascade 
by death receptors and other indicators of external stress. These caspases are generally 
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responsible for activating the rest of the apoptotic cascade within the cell including the 
effector caspases (104). The effector caspases, primarily caspase 3 and 7, directly induce 
apoptosis within the cell by cleaving the cytoskeleton and structural protein substrates 
involved with DNA repair/fragmentation, signaling, and protein repair/transcription 
(105). The cleaving process leads to cytoplasmic condensation, nuclear shrinkage, DNA 
cleavage, membrane blebbing and plasma membrane permeabilization (106). The 
conclusion of apoptosis is recognized by cell shrinkage as the cellular contents are 
packed into membrane-enclosed apoptotic bodies targeted for removal by phagocytosis. 
Phagocytosis is initiated through externalized signaling molecules, cell death-associated 
molecules such as phosphatidylserine, which is a phospholipid transferred to the 
exoplasmic leaflet of the cell membrane by the enzyme scramblase, which recruit 
phagocytic cells to engulf the apoptotic bodies without inducing an inflammatory or 
immunogenic response (107, 108). 
As seen in this study and most other contemporary studies, there is a binary 
assessment on cell death pathway type, either necrosis, premature inflammatory cell 
death, and apoptosis, programmed cell death. However, recent studies have found that 
cell death processes are more complex than previously understood. Two other 
programmed cell death pathways being explored further currently are pyroptosis and 
necroptosis (107, 109-113). In fact, it has been observed that these cell death processes 
are inherently inter-related and may not be mutually exclusive, which can cause 
difficulties in understanding the differences (109). 
Pyroptosis is caspase 1-dependent programmed cell death, which leads to rapid 
cell lysis and release of cytosolic contents into the extracellular space resulting in an 
inflammatory response. Since this cell death pathway involves caspase activity it was not 
differentiated from apoptosis until recently, when it was determined that pyroptosis was 
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dependent only on caspase 1, which is not involved in apoptosis. Furthermore, 
mitochondrial permeabilization, cytochrome c and other caspases are not involved in this 
cell death process (110). Pyroptosis is a host cell death, stimulated by microbial 
infections and non-infectious molecules, which initiate the process through toll-like 
receptors, externally, and nod-like receptors, internally. Caspase 1 is activated, which 
cleaves structural proteins to produce plasma membrane pores, increasing the water 
influx, leading to cell swelling and osmotic lysis. This lysis allows for the release of 
inflammatory contents, such as secreted inflammatory cytokines (IL6 and IL8) (109). 
Necroptosis, alternatively, is a caspase-independent programmed cell death that 
exhibits the same cell death morphology as necrosis. Necrosis is accidental cell death due 
to external injury, whereas, necroptosis is programmed and induced through cell death 
receptors such as CD 95 and tumor necrosis factor receptor 1 (TNFR1), which is the most 
studied (107, 111-113). This process is initiated after ligation of TNFR1 with TNF or 
other antibodies. At this point, the process may lead to cell repair, apoptosis or 
necroptosis. After ligation, receptor-mediated conformational changes occur recruiting 
the complex I, which chooses between cytoprotective and cytotoxic cascades. If 
continuing along the cytotoxic cascade, ligand-bound TNFR1 is internalized forming the 
death-inducing signaling complex (DISC) or complex II, which can stimulate either 
apoptosis or necroptosis. If caspase 8 is deleted, depleted or inhibited, a necroptosis-
signaling complex is formed through kinase activity of receptor interacting protein 1 and 
3 (RIPK1 and RIPK3) leading to necroptosis. Necroptosis is executed through such 
mechanisms as the lethal decline of ATP and reactive oxygen species generation (107). 
The cellular disintegration phase is similar to necrosis, except it occurs at a later stage 
preceding the defined signaling phase, in which oxidative bursting occurs, the 
mitochondrial membrane hyperpolarizes and the lysosomal and plasma membrane 
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permeabilizes and ruptures. This leads to spilling of intracellular contents and the 
inflammatory and immunogenic response (111).  
Our investigation focuses on understanding the cell death pathways that occur due 
to GNR-mediated photothermal therapy, therefore we differentiate between inflammatory 
and non-inflammatory cell death processes. Consequently, in this study the preferred 
method of cell death is apoptosis, which will limit the extracellular damage due to a lack 
of inflammatory and immunogenic response. The photothermal parameters necessary to 
induce apoptotic cell death at significant levels were investigated in this study. For 
apoptosis and necrosis discrimination, we utilized a fluorescent assay kit composed of 
propidium iodide (PI) and YO-PRO-1, purchased from Life Technologies. The YO-PRO 
dye is a carbocyanine nucleic acid stain that can pervade into apoptotic cells due to the 
slight membrane permeability, whereas the PI is a DNA-binding stain that is excluded 
from cells with intact or slightly permeable membranes and will only infuse into the 
necrotic cells (114). We utilized a standard technique, flow cytometry, to obtain 
quantitative values for the fluorescence intensity, for each stain, per cell after 
photothermal treatment. 
1.8 FLOW CYTOMETRY 
Flow cytometry is the standard method of quantitatively identifying size, 
morphology and fluorescent intensity of individual cells (115). Fundamentally, the device 
utilizes microfluidic techniques to line up cells single-file such that we can probe the 
properties of individual cells. As each cell moves through the device, it is exposed to a 
laser at a specific wavelength and light is collected at an angle and on the opposite side to 
obtain side scattered and forward scattered light, respectively. The forward scattered light 
corresponds to the cell size and the scattered light corresponds to the cell density. These 
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two values are powerful; researchers have used this data for such things as identifying 
cell type and viability, based on morphology, as well as differentiating between cells. In 
addition to the scattering values, there are also PMT optical detectors with bandpass 
emission filters to detect fluorescent light emitting from the cell after excitation. 
Therefore, using flow cytometry, we can observe the relative amount of fluorescence 
intensity within each individual cell. As a result, flow cytometry has been used 
extensively for quantitatively analyzing cell death pathways in cancerous cells (114, 116-
120). Furthermore, it has been used specifically for the assessment of drugs as an 
effective method of inducting apoptosis as a cancer therapeutic (121-124). Consequently, 
using the YO-PRO and PI stains we can quantitatively determine the fluorescence 
intensity in each cell and the necrotic or apoptotic nature of the cell (114). However, it 
has not been explored with regards to photothermal therapy to quantitatively understand 
the cell death pathway response to the localized heating, which will be performed in this 
study. 
1.9 MULTICELLULAR TUMOR SPHEROIDS 
A major shortcoming of GNP oncological research has been its reliance on two-
dimensional monolayer cell culture for experimentation. Because GNRs must penetrate 
into three-dimensional in vivo tumors, the results yielded from monolayer experiments 
are not entirely applicable to tumor therapy. The solution to this problem exhibited in this 
experiment is the use of multicellular tumor spheroids (MTSs), matrix-embedded three-
dimensional cell cultures used as in vitro models of tumors. MTSs offer great 
resemblance to the micro-regions of solid in vivo tumors in terms of structure and growth 
kinetics and thus serve as a more sensible medium for cancer therapy experimentation. 
MTSs were originally conceived in the 1940s and 50s, and then Sutherland et al. used 
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these tumor models to study the effectiveness of chemotherapeutic drugs in 1971 (125, 
126). They have been overshadowed by easily produced monolayer cell cultures for the 
past few decades, but have recently undergone a resurgence due to their uniquely 
accurate modeling of tumor physiology (127). New techniques, such as nanotechnology-
based drug delivery and imaging with two-photon microscopy, allowing thin optical 
sectioning and deeper optical imaging instead of having to physically section the MTS, 
lend themselves well to studies with MTSs. MTSs have also considerably expanded 
knowledge of tumor extracellular matrices, microenvironments, and tissue dynamics 
(127-129).  
MTS retain the functional and morphological features of in vivo tumors, follow 
predictable growth kinetic patterns, and are easily mass-produced for large-scale studies, 
with MTS having minimal variations in size and shape. The ability of MTS to be 
produced on a large scale allows them to serve as an economical, cost-effective 
alternative to inducing cancer and harvesting tumors in vivo. Several growth regions 
characterize tumor structure and closely resemble analogous regions in tumors: a 
capillary zone of nutrient and oxygen transfer at the MTS surface, a zone of 
differentiation and cell growth directly below the surface of the MTS, a quiescent zone of 
cells in a state of quiescence and a central zone of necrotic cells (125).  
MTS, like in vivo tumors experience an inward proliferation of cells during 
growth; exhibits clearly defined glucose, oxygen and nutrient gradients and accumulate 
metabolites and catabolites when healthy. Furthermore, MTS can become hypoxic in 
their most nutrient-deficient regions, and as a result of these substantial gradients, have 
been shown to be resistant to anti-cancer therapeutics at similar levels as in vivo tumors 
(130, 131). Analysis of cancer cells within MTSs has shown a higher degree of 
morphological and functional differentiation than cells grown in monolayer culture.  
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Another distinct advantage of MTS is the fact that they more accurately display 
the cell-cell and cell-matrix interactions seen in in vivo tumors. These cell-cell and cell-
matrix interactions play a large role in tumor responses to drugs including enhancing the 
cellular repair, and monolayer cultures do not effectively take these external factors into 
account, making MTSs a much stronger model of cancerous tumors (125). The 
extracellular matrix (ECM) formation creates a barrier to drug and nanoparticle delivery. 
These MTS, like their counterparts in in vivo tumors, also displayed growth kinetics, 
distributions of biological response modifiers and survival signals, metabolic rates, and 
resistance to radiation therapy and chemotherapy. Furthermore, their response to 
treatment may be affected by potential penetration barriers (ECM), altered expression 
profiles or signaling pathways of particular targets, such as the variation of DNA damage 
and repair mechanisms. By varying the size of MTS for treatment, the MTS experiments 
can be focused on 3D cellular interactions and structure only or in combination with 
authentic pathophysiological milieu conditions (127). Consequently, MTS have been 
studied extensively as an effective in vitro model for economical, high throughput testing 
of drugs and cancer therapeutics (132-135). Primarily, these studies observe the overall 
drug distribution and examine the therapeutic effects, which are frequently affected by 
the ability of the therapeutic to distribute uniformly throughout the MTS (136). As a 
result, many studies explore methods of enhancing the penetration and uptake and inspect 
the therapeutic improvement (137-140). In this study, we will examine two different 
delivery techniques to understand the differences in cell death pathway responses to 
photothermal therapy with disparate GNR distributions. 
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Chapter 2:  Nanoparticle-mediated Photothermal Therapy: 
Determining Photothermal Efficiency and Cell Death Dependence on 
Nanoparticle Localization 
2.1 INTRODUCTION 
In this chapter, we aim to compare the capability of nanoshells and nanorods to 
generate heat based on their number density, mass gold and optical density for 
photothermal therapy.  We simulated the optical properties of multiple sizes of nanorod 
and nanoshell, including our sized GNPs, using the discrete dipole approximation (DDA) 
and Mie theory.  The heating profiles were measured of GNPs suspended in tissue 
simulating phantoms during a photothermal heating cycle and compared to determine the 
heat generation when nanoshells and nanorods were at equivalent number densities.  We 
determined that nanoshells generated more heat than nanorods at equivalent number 
densities and that it was necessary to have ~36 times the number of nanorods as 
nanoshells to generate the same amount of heat.  However, at equivalent optical densities 
we determined that nanorods generate ~2 times as much heat as nanoshells and calculated 
that the nanorods have twice the photothermal transduction efficiency as nanoshells.  We 
believe that these results can be a comprehensive aid in determining the optimal GNP 
geometry for photothermal therapy. 
Our subsequent objective was to show that there is a dependence on GNR 
localization on the efficacy of nanoparticle-mediated photothermal therapy, by measuring 
the power and temperature thresholds for inducing damage.  Photothermal therapy can 
induce cell damage, through either a necrotic or apoptotic pathway, at differing laser 
powers depending on the localization of GNRs.  The apoptotic pathway seems ideal, 
because it should require less heating to induce and will cause intracellular damage, 
which means the damage can be localized without causing injury to the surrounding 
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tissue.  Therefore, determining the nanoparticle localization that corresponds to specific 
cell damage pathways and lower laser power thresholds can increase the efficiency of 
photothermal therapy.  We demonstrated this by measuring the laser fluence rate 
(W/cm
2
), power density over a certain area, threshold difference between GNRs localized 
to the cell surface and GNRs internalized within the cell, affecting specific cell death 
pathways for photothermal destruction. 
We utilized GNRs targeted to two different cancer cell components, 
extracellularly bound to the cell membrane and the internalized in the cell, which were 
localized to the perinuclear space. We confirmed localization of the GNRs using TPM 
and performed photothermal therapy by irradiating the cell samples containing GNRs 
with an NIR laser.  The fluence rate and temperature thresholds for each GNR 
localization was determined to be significantly less in each case for the internalized 
GNRs.  Through these experiments, we have determined that GNR-mediated 
photothermal therapy of cancer cells appears to depend on the localization of the GNR, 
which indicates that different cell death pathways and mechanisms are possibly being 
induced by the different GNR localizations. To further this study, we can determine 
whether the actual cell death pathway response is also dependent on GNR localization 
during photothermal therapy. Utilizing this knowledge, we can optimize GNR-mediated 
photothermal therapy by determining the ideal GNR location to induce cell death.  
2.2 RELEVANT WORK 
NIR absorbing plasmonic nanoparticles enhance photothermal therapy of tumors. 
In this procedure, systemically delivered gold nanoparticles preferentially accumulate at 
the tumor site and when irradiated using laser light, produce localized heat sufficient to 
damage tumor cells.  Gold nanoshells and nanorods have been widely studied for this 
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purpose, and while both exhibit strong NIR absorption, their overall absorption and 
scattering properties differ widely due to their geometry.      
Comparisons between nanoshells and nanorods have been studied previously (10, 
141-143).  Studies have determined that nanorods have a higher temperature increase per 
mass gold (141) and that the absorption cross-section of nanorods is two times higher 
than nanoshells (142).  Furthermore, several studies have been published regarding the 
photothermal efficiency of GNPs (10-12, 143, 144).  Both Cole et al. and Cheng et al. 
have compared gold nanoshells with nanorods but come to differing results.  The Cheng 
study has a different formulation for determining the photothermal efficiency than we 
utilize in the current study, which is based on number density of the GNPs (as opposed to 
optical density) and finds that nanoshells are more efficient (143).  Whereas, the Cole 
study follows a similar efficiency definition as we discuss in the current study, utilizing 
an energy balance equation to derive the efficiency based on previous work, to find that 
nanorods were more efficient than nanoshells (10, 12, 144). However, all of these studies 
disregard the multiple methods of comparison used to evaluate nanoparticles, as well as 
the size factor that greatly influences the GNP optical properties and the photothermal 
properties; as a result, we will explore those problems in greater detail within this study. 
One group has studied the targeting abilities of folate-conjugated gold nanorods to 
KB (oral epithelium carcinoma) cells that overexpress the folate receptor (72).  Using 
TPM the authors confirmed that the conjugated nanorods bound to the membrane of KB 
cells and were internalized with nuclear localization occurring after 6 hours incubation 
with the KB cells.  The authors performed photothermal therapy on the samples with 
membrane bound gold nanorods and internalized nanorods, speculating that cell death is 
caused by membrane blebbing.  It was determined that incident continuous wave (CW) 
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laser treatment for photothermal therapy with membrane bound nanorods required less 
power to induce cell damage than the internalized nanorods for irradiation types.   
Recently another group measured the difference in cell damage pathways and 
photothermal therapy between gold nanospheres localized to the cytoplasm and targeted 
to the nuclei (73).  In this study, the authors found that irradiated with a CW laser the 
nanospheres localized in the cytoplasm induced cell damage at energies of 108-114 J, 
whereas at 210 J the nanospheres targeted to the nuclei did not induce any cell damage.  
For the pulsed laser, the energy necessary to induce cell death in cytoplasm localized 
nanospheres was 0.8-1.0 mJ and 0.3-0.45 mJ for nuclear targeted nanospheres.  Thus, we 
see that the nuclear targeted nanospheres are more effective in inducing cell damage 
when irradiated with a pulsed laser but less effective with a CW laser, and the energy 
necessary to cause damage is much less with a pulsed laser than a CW laser. 
2.3 EXPERIMENTAL METHODS 
2.3.1 Nanoparticle Fabrication 
Nanospectra Biosciences, Inc. (Houston, TX) provided concentrated nanoshell 
and nanorod solutions.  The fabrication process for both GNPs has been discussed in 
detail previously (145, 146).  To determine the GNP size, we imaged (Figure 1) dilute 
solutions using transmission electron microscopy (TEM).  The dimensions were averaged 
over 300 individual particles, for both GNPs, measured in the TEM image using ImageJ 
(NIH Bethesda, MD).  The nanoshells were found to have a total outer diameter of 145 
nm ± 11.7 nm, with a silica core diameter of 120 nm (Figure 1).  The nanorod dimensions 
were measured to be 25.8 nm ± 3.8 nm by 7.4 nm ± 0.9 nm, with an aspect ratio of 3.5 
and an effective radius of 6.18 nm (Figure 1).  The effective radius, reff, is defined as the 
radius of a sphere with an equivalent volume (V) as the nanorod: 
 27 







During the fabrication process, Nanospectra Biosciences modified the GNP surface with 
polyethylene glycol (PEG) to mimic the GNPs that are used in vitro and in vivo.  To 
measure the extinction spectra and optical density for the nanoparticle solutions, we used 
a UV-Vis Spectrophotometer (Beckman Coulter DU720, Brea, CA). 
 
 
2.3.2 Nanoparticle Optical Simulations 
Using Mie theory and the discrete dipole approximation (DDA), we simulated 
nanoshell and nanorod optical properties, respectively. The dielectric function for bulk 
gold, determined by Johnson and Christy (J&C), was used for the nanoshell and nanorod 
Figure 1:  Gold Nanoparticles.  Gold nanoshells were fabricated with a silica 
core and gold shell and using TEM imaging were measured to 145 
nm in diameter.  Gold nanorods were fabricated as a cylinder with 
hemispherical caps and measured using TEM a size of 25.7 nm by 
7.4 nm. 
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simulations (147).  The dielectric function for bulk gold was corrected based on the small 
size of both the nanoshells and nanorods (33).  The size correction includes an additional 
damping term in the dielectric function due to collisions of conduction electrons to the 
GNP surface (33, 37).   
We used a DDA program, DDSCAT 7.0, to model nanorod optical properties 
using the lattice dispersion relation (31).  The DDA program approximates the scattering 
and absorption of any arbitrary geometry by modeling the target as a series of polarizable 
points. The nanorod geometry was modeled as a cylinder surrounded by water (34, 47). 
The DDSCAT program divides the particle into Id polarizable points (dipoles), which are 
on a lattice described by an interdipole distance d, based on the particle volume, V: 
      
  (3) 
The number of dipoles is chosen by the following accuracy criterion: 
 | |       (4) 




), which all simulations performed in the DDSCAT software satisfy. 
For the nanoshell optical properties, we utilized the Mie solution, because it is an 
exact solution to Maxwell’s equations for concentric spheres.  The nanoshells were 
modeled as an individual, gold-coated silica particle surrounded by water.  To perform 
the calculations we used Maetzler’s MATLAB Mie Theory code for coated spheres 
(148).  The nanoshell dielectric function was divided in two parts: (1) the inner core of 
silica was derived by Malitson and (2) the same size-corrected dielectric function for the 
gold shell as derived by J&C (147, 149).  
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With the nanorod and nanoshell absorption and scattering efficiency from DDA 
and Mie Theory we were able to determine the expected absorption and scattering 
coefficient (µa and µs): 
                 (5) 
                 (6) 
where σa and σs are the absorption and scattering cross-sections (cm
2
) and N is the GNP 
number density (#/mL). The concentration of GNPs is known; thus, only the absorption 
cross-section needs to be determined, which is equivalent to the multiplication of σg, the 
geometric cross-section (cm
2
), and Qa, the absorption efficiency (Eq. 1). The absorption 
efficiency represents the ratio of the absorption and geometric cross-sections.   
2.3.3 Experimental Procedures 
We performed two sets of experiments to determine the concentration 
equivalency factor (ξ) in tissue phantoms and the photothermal transduction efficiency, 
respectively (defined later in this study). To simulate the environment within tissue, the 
GNPs in the experiments for the concentration equivalency factor were suspended in 
tissue phantoms at multiple concentrations. To calculate the photothermal transduction 
efficiency, it was necessary to have the sample of GNPs suspended in a non-absorbing 
and non-scattering media to simplify the solution for the photothermal transduction 
efficiency. As shown in Equation 8, the OD was included to correspond to the extinction 
of specifically the GNPs and not the sample as a whole. Additionally, scattering 
processes would increase the fluence at the solution surface, but also would attenuate the 
fluence deeper in the solution, which could cause artificial increases or decreases in 
photothermal efficiency. As a result, we conducted the experiments on GNPs in a 10% 
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trehalose solution, which has the same optical characteristics as water in the wavelength 
range of interest. 
2.3.4 Concentration Equivalency Factor Experimentation 
The concentration equivalency factor defines the relationship between the 
concentrations of nanorods and nanoshells when heat generated from both solutions are 
equivalent. To determine this value we have to find the amount of heat generated from 
nanorods and nanoshells at multiple concentrations, to find the concentration of 
nanoshells and nanorods at which the generated heat is equivalent. The temperature 
change at the end of the heating cycle for the nanoshells, dTNS, and nanorods, dTNR, 
indicate the heat generated by each particle type during the procedures.  The ratio of the 
temperature change at a fixed concentration of nanoshells,  dTNS, (1x or 2x) to the 
temperature change of varying concentrations of nanorods, dTNR, (5x – 80x). Thus, the 
concentration equivalency factor (ξ = dTNS/dTNR) is the ratio of the determined 
concentrations, respectively.   
For this experiment, we prepared tissue phantom solutions composed of diluted 
10% intravenous fat emulsion (Liposyn II 10%, Abbott Laboratories, North Chicago, IL) 
and 90% dH2O, which mimicked the scattering properties of tissue. This dilution  
resulted in  a solution with similar scattering values to normal human epithelial tissue, µs’ 
= 1 mm
-1
, at the irradiation wavelength (150). The experimental control was a sample 
with the intravenous fat emulsion dilution without GNPs. The GNPs were suspended in 
the tissue phantom solution at multiple concentrations including: 1x, 2x, 5x, 10x for the 
nanoshells and 5x, 10x, 20x, 40x, and 80x for the nanorods, where x is the nominal 
physiological concentration. The physiological value, x = 1.14 x 10
9 
GNPs/mL, is based 
on previous biodistribution studies of nanoshells in tumors in mice after intravenous 
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injection (151, 152). The corresponding concentration for nanorods is unknown; hence, in 
this study we determined the concentration of nanorods at which the same amount of heat 
is generated as nanoshells at the physiological concentration.  
2.3.5 Photothermal Transduction Efficiency Experimentation 
The photothermal transduction efficiency denotes a value for the efficacy of gold 
nanoparticles converting absorbed light radiation into thermal energy. For determining 
the photothermal transduction efficiency, we prepared a set of different samples.  In this 
study, the GNPs solutions were suspended in 10% trehalose at a set optical density of 
0.25 at the irradiation wavelength (808 nm). The control for this experiment was a 
solution of 10% trehalose. All GNP samples were pippetted into a 96-well plate (BD 
Falcon, Franklin Lakes, NJ). 
The calculation of the photothermal transduction efficiency for both nanoshells 
and nanorods was conducted in a similar method to Roper and coworkers (12). Using an 
energy balance for our experimental system, we determined the photothermal 
transduction efficiency. The total energy balance is: 
    
  
  
                       (7) 
where m  and Cp are the solvent (10% trehalose) mass and heat capacity and T is the 
sample temperature. Ein,np is the energy input based on the heat dissipated by the 
nanoparticles in the solution: 
             
      (8) 
where I is the laser power, OD is the sample optical density at the excitation wavelength 
of 808 nm, and η is the photothermal transduction efficiency, fraction of absorbed light 
converted into heat. Ein,sample is the energy input based on the heat generated by the 
solvent and sample well, which was measured independently following the same method 
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of solving for Eext with the experimental control of trehalose solution.  Eext is the energy 
output based on the external heat flux between the sample and the surroundings: 
                       (9) 
where h is the heat transfer coefficient, A  is the sample well surface area, Tsample is the 
temperature of the sample, which in our case is the steady state maximum temperature, 
and Tamb is the ambient room temperature.   
We determined the quantity, hA, by measuring the sample cooling after the laser 
was turned off.  When the laser is turned off Equation 7 becomes: 
    
  
  
                         (10) 
Rearranging Equation 10: 
     
   
  
  
           
 (11) 
After integrating Equation 11: 
    (
   
  
)               (12) 
From this equation, we can determine the characteristic rate constant: 
      




              ( 
 
    
) (14) 
Thus, from the cooling data, we can determine the characteristic rate constant and solve 
for the heat transfer coefficient. At the steady state temperature, the rate of heating is 
equal to the rate of heat transfer out of the system: 
                        
                     
                
(
(15) 
As a result, the photothermal transduction efficiency can be solved for directly 
from the steady-state temperature experiments: 
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 (16) 
2.3.6 Instrumentation 
We used an InSb infrared (IR) camera (FLIR Systems SC4000, Boston, MA) with 
a spectral range of 3-5 µm, to measure the heating characteristics of the sample.  The IR 
camera was placed directly above the 96-well plate and a laser was mounted at an angle 
of approximately 30° such that the sample was irradiated completely while not interfering 
with the imaging (Figure 2). We used a fiber-coupled NIR (λ = 808 nm) diode-laser 
(ThorLabs L808P1WJ, Newton, NJ) rated for up to 1 W of power. Using a biconvex lens 
(Newport Corp., Irvine, CA) the laser spot was focused to 6 mm in diameter, 
approximately the same diameter as the well. 
 
Figure 2:  Instrumentation. Gold nanoparticle solutions were prepared in 96 well plates 
and illuminated at a slight angle by a diode laser (808 nm) focused onto the 
sample by a biconvex lens.  An infrared (IR) camera was placed above the 
sample to measure the increase in temperature of the solution with respect to 
time. 
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2.3.7 Photothermal Experiments 
Each sample was illuminated at a constant fluence rate of 2 W/cm
2
. Prior to each 
experiment: we sonicated and mixed the sample thoroughly to create a uniform 
distribution of GNPs, and confirmed the laser power using a standard power meter 
(Newport Corp., Irvine, CA). We selected a region of interest at the laser spot center and 
solution to measure the sample heating and the cooling after the laser was turned off, 
using the ThermoVision software (FLIR Sys., Boston, MA). For the tissue phantom 
experiment, we heated all samples for 5 minutes, to mimic current in vitro and in vivo 
photothermal studies, and let the sample cool to room temperature for 10 minutes after 
the laser was turned off. For the photothermal transduction efficiency experiment, we 
heated the samples to steady state, which occurred after approximately 25 minutes of 
irradiations and let the samples cool to room temperature for around 20 minutes. All 
comparisons and analyses were performed in MATLAB (The Mathworks Inc., Natick, 
MA).   
2.3.8 Cell Culture 
In the second part of this study, we wanted to determine whether the PEG and 
CTAB GNRs were targeted to two separate localizations on and within human colorectal 
carcinoma cells. Human colorectal tumor cells (HCT-116, ATCC, Manassas, VA) were 
seeded in T25 flasks with cell culture media composed of McCoy’s Modified Medium 
(Corning CellGro, Corning, NY) supplemented with 10% fetal bovine serum (FBS) and 
1% penicillin-streptomycin-amphotericin B (Lonza, Basel, Switzerland) at 37°C with 5% 
CO2. After the cells reached confluence, we detached the cells with 0.5% trypsin solution 
(Thermo Scientific HyClone, Waltham, MA) and centrifuged at 600 RPM for 5 minutes. 
The cells were seeded into 6-well plates containing a coverslip in each well. After the 
cells reached confluence on the slides, we removed the old media incubated them with 
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the respective GNRs (PEG and CTAB) immersed in McCoy’s Media at a 0.25 optical 
density (OD) ranging from 6-24 hours. Then we removed the GNR-media solution and 
washed the cells with phosphate buffered saline (PBS) three times to ensure that all free 
GNRs were removed.   
2.3.9 Two-Photon Imaging 
The cellular nuclei were then stained with CellMask plasma membrane stain (Life 
Technologies, Carlsbad, CA) as a reference to demonstrate GNR location and the cells 
were fixed with a 4% paraformaldehyde solution. The coverslips were then placed on a 
glass slide with mounting media (Vectashield, Vector Laboratories, Burlingame, CA), 
sealed using nail polish, and imaged using TPM (Prairie Technologies, Middleton, WI). 
Imaging was done with an ultrafast pulsed femtosecond tunable Ti:Sapphire laser 
(Spectra Physics Mai-Tai, Irvine, CA). The laser was tuned to 800 nm to image the gold 
nanorods and 750 nm to image the plasma membrane stain. To image the emitted light, 
we used photomultiplier tubes (PMTs) with a 660 nm +/- 20 nm bandpass filter for the 
gold nanorods (Channel 1) and 595 nm +/- 50 nm bandpass filter for the plasma 
membrane stain (Channel 2). The cells were imaged with a water-immersion 60x 
objective (Olympus) with a 1.0 NA allowing for a high resolution and high 
magnification. All images were taken with the proprietary software (PrairieView) and 
analyzed with ImageJ. 
2.3.10 Photothermal Therapy 
After determining the GNR localization, we performed photothermal therapy on 
the HCT-116 cells with the respective GNRs. Here, cells were seeded from T-75 flasks as 
above, but into 12-well plates. Again, we let the cells grow to confluence before 
incubating the respective GNRs suspended in McCoy’s media with the cells for 24 hours.  
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After removing the GNRs, we washed 3 times with PBS. We then irradiated each sample, 
while the overall temperature was maintained at 37° C on a hot plate, with a diode laser 
(λ = 808 nm) (ThorLabs, Newton, NJ) for 5 minutes while measuring the temperature of 
the laser spot size (0.2 mm) using an InSb infrared camera (FLIR Systems SC4000, 
Boston, MA) with a wavelength detection range of 3-5 µm. We increased the laser 
fluence rate from 5-40 W/cm
2
 to determine the lowest fluence rate, or threshold, to 
induce cell death for the respective GNRs. The sample temperature increase measured at 
the fluence rate threshold for each respective GNR was determined as the temperature 
threshold. To allow for cell death pathways to transpire, we waited 24 hours after 
irradiation to stain for cell death and imaged thereafter using a bright-field microscope. 
To demonstrate cell death, we stained the cells with Trypan blue (Thermo Fisher 
Scientific, Waltham, MA), which stains nonviable cells with compromised membrane 
integrity and imaged under a bright-field microscope.   
2.4 RESULTS  
2.4.1 Gold Nanoparticle Optical Properties 
The GNP optical properties were determined using simulations with the measured 
size parameters as input. The plots in Figure 3 illustrate the simulated optical efficiency 
spectra and measured extinction spectrum for GNS. The resonance peak wavelength was 
found to be the same for both the simulated and measured extinction spectra (780 nm) 
indicating the validity of the Mie theory simulation. The simulation (Figure 3a) shows the 
nanoshells are highly scattering (~75% of the extinction efficiency), and they have an 
absorption efficiency of 1.9 at the laser wavelength of 808 nm. Given the absorption 
efficiency, the calculation for the absorption cross-section follows from Equation 1, with 







Figure 3:  Gold nanoparticle optical properties. The extinction, absorption, and 
scattering efficiencies of gold nanoshells (a) and gold nanorods (b) were 
simulated using Mie theory and DDA, respectively. The gold nanoshell 
measured extinction spectra (a) peak matches with the peak of the 
efficiencies; additionally, gold nanoshells were found to be high scattering. 
Gold nanorods (b) were found to have virtually no scattering component 
(0.2% of extinction) for multiple aspect ratios (3.0–3.5), therefore, only 
shown is the absorption efficiency of the different aspect ratios in 
comparison to the measured optical density of our gold nanorods with an 
aspect ratio of 3.5. 
Figure 3b illustrates the simulated absorption efficiency spectra as compared to 
the measured gold nanorod extinction spectrum. The simulated absorption efficiency 
shows a resonance peak wavelength that is red-shifted (812 nm) in comparison to that 
wavelength from the measured extinction spectrum (770 nm). We varied the nanorod 
length to change the aspect ratio from 3.5 to 3.0, resulting in a peak resonance blue shift. 
The aspect ratio that best matches the measured value was approximately 3.3. In all 
cases, the absorption efficiency accounted for approximately 99.8% of the extinction 
efficiency. These results suggest that nanorods in this size range are completely 
absorption dominated, and after simulating multiple aspect ratios we have found an 
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absorption efficiency that is a good indicator of the individual nanorods used in this 
study. We found the absorption efficiency value to be 4.9 for the nanorods, and utilizing 




.   
2.4.2 Photothermal Heating 
We measured the heating response of both gold nanoshells and nanorods in tissue 
simulating phantoms to determine the ξ factor. Figure 4 shows the temperature profiles 
for the nanoshells and nanorods for 5 minutes of heating and the subsequent cooling 
cycle. Both GNP types exhibit a significant temperature rise in comparison to the 
experimental control (0x) when illuminated by NIR light. The temperature change (after 
5 minutes of heating) ranged from approximately 12°C to 42°C for concentrations of 1x 
to 10x of gold nanoshells. However, for the gold nanorods, the temperature change (after 
5 minutes heating) ranged from approximately 3° C to 17°C for concentrations of 5x to 
40x. The temperature change increased as the concentration increased.  
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Figure 4:  Gold Nanoparticle Temperature Change.  (a) Measured temperature change 
of increasing concentrations (0x, 1x, 2x, 5x, and 10x) of gold nanoshells in 
tissue phantoms.  (b) Measured temperature change of increasing 
concentrations (0x, 5x, 10x, 20x, 40x) of gold nanorods in tissue phantoms.  
All temperatures were measured during 5 minutes of illumination with a 
diode laser (λ = 808nm) at a fluence rate of 2 W/cm
2
 and 10 minutes of 
cooling after the laser was turned off. 
To determine the ξ factor, interpolation was performed for all nanorod 
concentrations between 5x and 80x using the power law (Figure 5). For the 1x nanoshell 
concentration, it is shown that the nanorod concentration when the ratio is equal to one is 
approximately 36. For the 2x nanoshell concentration, the nanorod concentration for heat 
generation equivalence is shown to be approximately 72. Therefore, we can conclude for 
these sized GNPs, to generate the equivalent heat, it is necessary to have a nanorod 
concentration 36 times the concentration of nanoshells. As with the per GNP heating 





). In fact, when compared to the nanorod absorption cross-section, the nanoshell 
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Figure 5:  Concentration Equivalency Factor ξ.  Plot shows the ratio of the temperature 
change of a single concentration of nanoshells (dTNS) and the temperature 
change at multiple concentrations of gold nanorods (dTNR).  The green and 
red lines are power law interpolations of the different nanoshell 
concentrations (1x and 2x).  The black line denotes when the ratio equals 
one.  The intersection of the black line with the red and green lines (as 
demonstrated by the arrows), indicates the concentration equivalency factor. 
2.4.3 Photothermal Transduction Efficiency 
To determine the photothermal transduction efficiency we fit equation 14 to the 
cooling data to determine the characteristic rate constant and the heat transfer coefficient 
(Figure 6) based on Equation 13. Both samples of GNPs were diluted to an optical 
density of 0.25 (inset of Figure 7) at 808 nm in a 10% trehalose solution. Using Equation 
16, the photothermal transduction efficiency for nanoshells and nanorods was determined 
to be ~25% and ~50%, respectively (Figure 7). Thus, nanorods are shown to be twice as 
efficient as nanoshells at converting the light radiation into thermal energy. 
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Figure 6:  Steady-state Heating of Gold Nanoparticles.  Gold nanoshell (lower 
temperature) and gold nanorods (higher temperature) were heated to steady-
state using fluence of 2 W/cm
2
 then let to cool down to room temperature.  
The heating and cooling temperature change were fit with exponentials to 
determine the heat transfer coefficient for solving the photothermal 
transduction efficiency. 
 
Figure 7:  Photothermal Transduction Efficiency.  Inset is of nanoshell (blue with 
squares) and nanorod (red with circles) extinction spectra diluted such that 
at 808 nm the optical density was the same (0.25) as denoted by the arrow.  
Bar plot of photothermal transduction efficiency shows gold nanorods (red, 
50%) are twice as efficient at converting light into heat as gold nanoshells 
(blue, 25%).  Error bars are standard deviation over multiple trials (n =3). 
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2.4.4 Gold Nanorod Absorbance 
The first step for our in vitro photothermal therapy experimentation was choosing 
GNRs for studying as it is more efficient photothermally than gold nanoshells (Figure 7). 
As a result, we characterized two types of GNRs, the (1) PEG and (2) CTAB GNRs, and 
determining their location with respect to the cell. Using UV-Vis, we determined the 
respective GNR optical densities and found that the CTAB GNRs had a slightly red-
shifted SPR peak in comparison to the PEG GNRs (Figure 8). This could be due to slight 
GNR aggregation in the sample measured. However, the shape of the curve with respect 
to wavelength was similar.  
 
 
2.4.5 Gold Nanorod Localization 
To validate our hypothesis that CTAB GNRs would be more attracted to the cells 
than PEG GNRs due to their surface charge, we imaged human colorectal cancer cells 
that had been incubated with both GNRs, respectively, for 24 hours to determine GNR 
Figure 8:  Absorbance spectra of CTAB and PEG GNRs. CTAB GNR peak SPR 
frequency is slightly red-shifted than the PEG GNRs. 
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location.  Through experimentation, we determined that 24 hours was a desired 
incubation time, because it allowed for a high concentration of GNRs to interact with the 
cell without inducing cytotoxicity. TPM allows for three-dimensional imaging due to its 
thin optical sectioning as discussed previously. We imaged the samples at several depths 
from which we could determine if the GNRs were located on or within the plasma 
membrane in all three dimensions (Figure 9).  
 
Figure 9:  GNR Cellular Localization. Included in each set of 3 images is: (1) imaged 
above the cell, (2) in focus with the cell membrane (green), (3) image below 
the cell. The PEG GNRs (red) are shown to be in the extracellular space, 
most likely non-specifically bound to the cell. The CTAB GNRs (yellow) 
are shown to be internalized and within the cytoplasm and perinuclear 
region. 
From the TPM images, it is clearly shown that the CTAB GNRs were within the 
cell membrane stain in the same imaging plane as the cells (Figure 9). Furthermore, the 
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CTAB GNRs were not in focus when imaged above and below in the Z-direction, 
therefore suggesting that the GNRs are not bound to the cell membrane. We observed 
that the GNRs seem to be aggregated, possibly localized to organelles within the 
perinuclear region (Figure 9). On the other hand, we detected that the PEG GNRs had 
limited internalization and seem to bind to the cell membrane at the 24 hour incubation 
time period. The PEG GNRs do not appear be within the cell membrane stain, but instead 
are limited to the extracellular space and are in focus when imaging below in the Z-
direction, therefore suggesting that the PEG GNRs are bound to the cell membrane 
surface (Figure 9). 
 
Figure 10:  Fluence Rate Threshold Determination. For both the PEG and CTAB GNRs 
the photothermal therapy does not induce cell death (Trypan blue) until 
fluence rate threshold, 30 W/cm2 and 19 W/cm2, respectively. 
2.4.6 In Vitro Photothermal Therapy 
After determining that the CTAB and PEG GNR cellular localizations were 
significantly different, we performed photothermal therapy on the samples, to determine 
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if there was a dependence on localization.  To determine the fluence rate threshold, we 
conducted several rounds of experimentation, increasing the fluence rate until we 
measured signs of cell death using the Trypan blue (Figure 10).  We found the lowest 
fluence rate to induce cell damage for photothermal therapy of CTAB (internalized) 
GNRs was approximately 19 W/cm
2
 with a temperature difference of 6.6°C ± 0.1°C 
(Figure 11).  In addition, we determined that the fluence rate threshold to induce cell 
damage for photothermal therapy with PEG (membrane-bound) GNRs was 
approximately 30 W/cm
2
, which corresponded to a temperature difference of 8.3°C ± 
0.2°C (Figure 11).  The difference in fluence rate and temperature thresholds indicates 
that there is a dependence on the GNR localization in initiating cellular death pathways 
during photothermal therapy. 
 
 
Figure 11:  GNR heating during photothermal therapy. Showing there is a significant 




2.5.1 Nanoparticle Optical Properties  
In this study, we simulated the optical properties of our sized nanoshells with Mie 
theory and determined an approximation of our sized nanorod optical properties with 
DDA (Figure 3). The nanoshells are scattering dominated and have a much lower 
absorption component than nanorods, whereas the nanorods were completely absorption 
dominated. However, to accurately compare the absorption properties of both GNPs, the 
overall geometric cross-section needs to be incorporated to determine the absorption 
cross-section.  We found the nanoshell absorption cross-section to be approximately 35 
times larger than the nanorod absorption cross-section. Thus, we would expect the 
nanoshells to generate more heat than nanorods per particle when illuminated with NIR 
light, despite their lower absorption efficiency. 
Based on this study and the study performed by Ungureanu and coworkers, it is 
apparent that DDA does not provide an accurate approximation to the optical properties 
of nanorods (37). In their study, they compared the simulated results with the measured 
extinction spectra of four different sized nanorods. The authors used four different shapes 
(cylindrical, hemispherically-capped cylinder, ellipsoid, and rectangular) and three 
different size-corrected dielectric functions for gold (J&C, Palik and Weaver) to model 
the gold nanorods (147, 153, 154). Based on their results, the authors found that the size-
corrected J&C and cylindrical shape gave the best results, but, it still was not completely 
accurate. However, we still performed the DDA in this study with the size-corrected J&C 
dielectric and modeling the nanorod as a cylinder as shown in Figure 3b to show that the 
nanorod optical properties are absorption dominated. 
There are a few areas of loss that are not accounted for in our model and 
experiment. Possible losses of heat generation include the metal distribution around the 
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GNP surface. When heated, the particle may elongate or compress, modifying the GNP 
geometry, which in turn may alter the optical properties and heating characteristics 
slightly. Additionally, since the temperature at the GNP surface cannot be determined, it 
is possible that there are heating effects in the direct surroundings of the GNPs. Even 
though the steady-state temperature is lower than boiling point due to losses to 
convection between the solution and air, the GNP surface temperatures can possibly 
reach boiling point. Consequently, phenomena such as localized evaporation could take 
place, which can cause cavitation bubbles. These steam pockets and cavitation bubbles 
may affect the GNP surroundings optically and physically, which is not taken into 
account in the experiment.   
2.5.2 Photothermal Heating 
In our photothermal tissue phantom experiments, the heat generated by different 
concentrations of both nanoparticle types was recorded. From these results, it was 
determined that the temperature increase was substantial and, most likely, would cause 
damage to cells as in all previous photothermal studies. Additionally, we observed that 
per individual GNP, the nanoshells, indeed, had the larger temperature change.   
However, if we compare the GNP heating based on their respective mass of gold, 
we observe a different result. The mass per GNP of nanoshell is 1.34 x 10
-8
 µg and for 
nanorod is 1.91 x 10
-11
 µg. At the 80x concentration of nanorods there is 0.58 µg gold in 
solution, corresponding to a ~25°C temperature change. We also compared this data with 
the 1x concentration of nanoshells, which corresponds to a mass of 5.03 µg gold in 
solution, accounting for only the shell, and a temperature change of ~14.8°C. Even at 
approximately 10 times smaller than the sample with the lowest mass gold of nanoshells 
used in this study, the sample with the highest mass gold of nanorods has a significantly 
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greater increase in temperature. Therefore, the nanorods can generate more heat per µg 
gold in comparison to nanoshells. 
This study was based on the known physiological dose of nanoshells that reach 
the tumor site in vivo. The heat generated by this concentration of nanoshells has been 
shown to be enough to cause cell death and a significant reduction in tumor size. In 
current literature, the same value is unknown for nanorods. As a result, the heat 
generation based on the physiologic dose of nanoshells was chosen as the low end 
threshold for determining the equivalent concentration of nanorods necessary to cause 
tumor ablation. According to the observed, to generate the equivalent amount of heat it is 
necessary to have 36 times the concentration of nanorods as the concentration of 
nanoshells, for these specific sizes of nanoshells and nanorods. When compared to the 
ratio of the simulated absorption cross-sections, it is remarkably similar.   
Our obtained data suggests that to achieve the same heating, a substantially larger 
number of nanorods would need to be present at the tumor site. Since the two GNPs have 
different sizes and shapes, likely there will be differences in the number of GNPs that 
reach the tumor sites. The comparative targeting efficiency of nanoshells and nanorods is 
unknown; therefore, it is possible that at similar doses to nanoshells, more particles can 
reach the tumor site. Effectively, if nanorods can reach the tumor site at a rate of 36 times 
more than nanoshells, then this would negate the lower heat generation, and it would be 
more efficient in converting the available laser power into heat. The choice of GNP may 
be an application dependent process. For example, it may be desired to have smaller 
GNPs, for more effective targeting or larger GNPs, for more heating with fewer particles. 
Further studies need to be performed to determine the targeting efficiency of both GNP 
types. 
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2.5.3 Photothermal Transduction Efficiency 
Another important finding in this study was the photothermal transduction 
efficiency. For this experiment, we heated both GNPs at the same optical density (at the 
illumination wavelength) to steady state and let cool to room temperature. The nanorods 
had a much larger temperature increase than nanoshells in this experiment as predicted by 
the simulations. The cooling data was modeled with a single exponential fit to determine 
the sample characteristic rate constant. Using this value, we determined the heat transfer 
coefficient, which in this model considers energy losses to the surroundings. 
Furthermore, we also modeled the control sample cooling data, which was heated to 
steady state, to determine the energy dissipated by the sample well. For our sized GNPs, 
it is important to note that these nanorods were found to be twice as efficient at 
transducing light radiation into thermal energy as nanoshells.  
2.5.4 Gold Nanorod Absorbance 
The GNRs used for the in vitro photothermal therapy experiment were fabricated 
with PEG and CTAB on the gold surface. During characterization, the optical density of 
both GNRs was measured and we determined that the profile was the same but the peak 
SPR frequency was shifted to a longer wavelength for the CTAB GNR (Figure 8). It is 
possible, that this is due to the CTAB GNRs being slightly less stable when removed 
from a solution with free CTAB as was performed to lessen the cytotoxicity. Therefore, 
there may be slight aggregation, which can lead to red-shifting of the optical density. 
However, to account for these differences, the GNR solutions were mixed to 0.25 OD at 
808 nm to correspond with the laser wavelength for photothermal therapy, for all 
experiments. 
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2.5.5 Gold Nanorod Localization 
In addition, since CTAB GNRs are cationic and the PEG GNRs are neutral, we 
hypothesized that the CTAB GNRs would be highly attracted to the cell due to the 
negative charge of the cellular membrane, whereas the PEG GNRs would only be non-
specifically bound to the cell. Furthermore, CTAB is a surfactant and lipophilic, which 
allows it to pass through the lipophilic plasma membrane into the cell. The CTAB GNRs 
were found to be internalized, using TPM, assembled in the perinuclear region, possibly 
near the mitochondria or nuclei. We believe that the initial attraction of the CTAB GNRs 
to the cell is due to the ionic differences in charge as discussed above (155). TPM images 
show that PEG GNRs were found at a lesser strength than the CTAB GNRs and primarily 
bound to the surface of the cell (Figure 9).  PEG induces a neutral GNR surface charge 
such that the GNR can freely move about in vivo without being recognized as foreign 
object.  However, this also indicates that the PEG GNRs will only non-specifically bind 
the cell surface and at a lesser extent than the CTAB GNRs. 
2.5.6 In Vitro Photothermal Therapy 
In our subsequent photothermal studies, we show that internalized GNRs, 19 
W/cm
2
, required significantly less laser power to induce cell death than the membrane-
bound GNRs, 30 W/cm
2
 (Figure 11).  We believe that this disparity is due to the different 
GNR localizations inducing different cell death pathways during photothermal therapy.  
Other groups have shown similar results that location plays a role in the power necessary 
to cause cell death (72, 73).  Huang et al. compared gold nanospheres targeted to the 
cytoplasm and nuclei and found that it depended on the laser delivery method, either 
using a pulsed or a CW laser.  However, in the Tong et al. study the authors suggest that 
membrane-bound GNRs result in cell death at a lower power than internalized GNRs, 
which is contrary from what we found.  The authors make some assumptions in their 
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study, such as using a pulsed laser in CW mode is only an approximation to actual CW 
laser. Therefore there are still pulses, albeit on the millisecond level, which could still 
induce photodestructive effects, such as bubble formation. Additionally, the final 
concentration of the internalized and membrane-bound GNRs is unknown; therefore it is 
possible that the final GNR concentrations skewed the results.  We believe that 
internalized GNRs should induce cell death with a lower temperature difference and 
power, because the GNRs would utilize the highly localized heating within the cell in 
close proximity to the most susceptible cellular components that induce apoptosis, the 
mitochondria and nuclei. 
Therefore, in this study, we sought to determine whether final concentration 
skewed our results.  As a result, we measured the temperature change to show that the 
temperatures required to induce cell death was statistically different for both the 
internalized (6.6°C) and membrane-bound (8.3°C) GNRs (p<0.001, Figure 11).  Since the 
temperatures reach steady-state, we can assume the sample is undergoing an adiabatic 
reaction, therefore: 
                     
where Q is thermal energy, μa is the absorption coefficient, Ψ is the fluence rate, ΔT is the 
change in temperature, ρ is the density of the solution (essentially water), and Cp  is the 
heat capacity of the solution.  The density and heat capacity of the membrane-bound and 
internalized samples are identical, and the absorption coefficient is directly proportional 
to the concentration.  Therefore, we solve for the effective concentration: 




If we compare the ratio of the Ceff for both the membrane-bound (0.3) and internalized 
(0.34) GNRs, we get a 12% difference in concentration.  However, if we look at the ratio 
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of the fluence rate thresholds for both GNRs we demonstrate a 37% difference.  
Therefore, we believe that the concentration is not the primary source of the difference in 
the fluence rate threshold. As a result, this indicates that the difference is because GNR-
mediated photothermal therapy is dependent on GNR localization. 
2.6 CONCLUSION 
Nanoparticle heating dynamics depend on a combination of factors that include 
their overall geometry and optical absorption efficiency. Ultimately, the appropriate 
choice of nanoparticle will depend on the application and the particle’s targeting kinetics. 
In this study, we determined the optical absorption efficiency for nanorods and the 
adjusted optical absorption efficiency for nanoshells per particle. Yet, due to the larger 
size of nanoshells, their absorption cross-section is much larger than nanorods. As a 
result, the nanoshells have a much larger increase in temperature than the nanorods on a 
per particle basis. Additionally, a higher nanorod concentration is required for equivalent 
heating of nanoshells, for the GNP sizes tested. However, in comparing the effectiveness 
of converting light radiation into thermal energy, the nanorods are twice as efficient.  
Both GNPs have utility in photothermal therapy depending on each particle’s ability to 
reach the tumor site. Therefore, with the information from this study, an educated choice 
can be determined on which GNP to use for photothermal therapy in vivo based on the 
respective GNP targeting efficiency.  
In addition, we determined that PEG GNRs were found to non-specifically bind to 
cell surface and CTAB GNRs were found to be internalized. The internalized GNRs had 
a lower fluence rate and thermal threshold for cell death during photothermal therapy 
than surface bound GNRs. To prove that the final concentration was not the primary 
factor in the fluence rate threshold difference we determined the thermal threshold 
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difference.  In conclusion, we have shown that localization of the GNR may be a factor in 
inducing different mechanisms or pathways of cell death during photothermal therapy. As 
a result, we have continued our studies in determining the effect of photothermal therapy 
and GNR localization on the cell death pathway response. 
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Chapter 3: Cell Death Pathway Dependence on Nanoparticle 
Localization during Photothermal Therapy 
3.1 INTRODUCTION:  
In this portion of the study, we aim to show that not only is the power necessary 
to induce damage for GNR-mediated photothermal therapy dependent on GNR 
localization, as shown in Chapter 2, but also that the cell death pathways are dependent. 
GNRs have been shown to induce localized heating to only the immediate surroundings; 
therefore, we believe the location should significantly affect the power necessary to 
induce damage and cell death pathways. Since the heat will be localized to certain 
organelles, essential to cell death processes, different cell death pathways could be 
induced. To perform this study, we targeted GNRs to different cellular localizations by 
varying the GNR incubation time with the cells. We confirmed GNR localization with 
TPM and performed photothermal therapy with a NIR diode laser. After irradiation, our 
final step involved quantitatively analyzing the cell damage threshold to determine the 
percentage of apoptotic and necrotic cells using flow cytometry. Utilizing this 
knowledge, we can better optimize GNR-mediated photothermal therapy by developing a 
better understanding of cell death pathway response to GNR localization. 
3.2 RELEVANT WORK  
Previous studies have indicated that GNP-mediated photothermal therapy is 
dependent on the localization of GNPs and investigated the effect on cell death pathways 
(72, 73, 156). Using folate-conjugated GNPs, one group showed that membrane-bound 
GNPs required a lower energy threshold necessary to induce damage during 
photothermal therapy than internalized GNPs (72). In another study, GNPs in the 
cytoplasm were shown to more effective at inducing cell death than GNPs in the nuclei 
with CW laser irradiation, but the opposite effect was observed for pulsed laser 
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irradiation (73). The authors demonstrated that the induction of apoptosis and necrosis is 
dependent on the localization of GNPs and the laser delivery method using qualitative 
assessments by imaging stained cells, with only necrosis being observed with the pulsed 
laser irradiation for both localizations. However, in a different study, the authors 
observed that apoptosis could actually be induced with pulsed laser irradiation and that 
necrosis had a higher energy threshold to induce damage than the apoptotic threshold 
(156). Due to the lack of quantitative analytical studies executed regarding the subject of 
cell death response to photothermal therapy, we believe that it is necessary to for a 
comprehensive study performing quantitative cell death pathway measurements on the 
effect of photothermal therapy.  
3.3 MATERIALS AND METHODS 
3.3.1 Gold Nanorod Synthesis 
We followed the same gold nanorod synthesis as previously done by Nikoobakht 
et al and Jana et al in a Ag(I) –assisted growth method (145, 157). Briefly, we made an 
aqueous gold seed particle solution is prepared by adding 250 µL of 0.01 M HAuCl4 
(Sigma Aldrich, St. Louis, MO)  to 9.75 mL of aqueous 0.1 M cetyl trimethylammonium 
bromide (CTAB, Sigma Aldrich, St. Louis, MO) solution in a vial, while stirring. Then 
we made a 0.01 M NaBH4 (CTAB, Sigma Aldrich, St. Louis, MO) solution by placing DI 
water in a vial, equilibrating it in an ice bath, adding the NaBH4, and mixing it rapidly. 
600 µL of the aqueous 0.01 M NaBH4 is added to the gold seed particle solution and 
stirred for 2 min. Next, an aqueous growth solution is prepared by combining 9.5 mL of 
0.1 M CTAB, 75 µL of 0.01 M AgNO3 (Sigma Aldrich, St. Louis, MO), 500 µL of 0.01 
M HAuCl4, and 55 µL of 0.1 M ascorbic acid (Sigma Aldrich, St. Louis, MO) in a 15 mL 
centrifuge tube.  Upon adding ascorbic acid, we inverted the tube two times to mix, 
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creating a colorless solution due to partial reduction of the gold salts.  12 µL of the gold 
seed solution was then added to this growth solution followed by slowly inverting it two 
times to mix, which was incubated at 27 °C overnight without stirring. The resulting 
GNR solution was centrifuged three times at 8000 RPM for 20 minutes to remove excess 
CTAB, to reduce the chance of cytotoxicity, and concentrated the solution in 15 mL of 
DI H2O. We measured the dimensions by averaging over 300 individual particles 
analyzed in ImageJ (NIH Bethesda, MD) using transmission electron microscopy (TEM, 
FEI Tecnai, Hillsboro, OR) images. We measured the optical density (OD) or absorbance 
of the solution using a UV-Vis Spectrophotometer (Beckman Coulter DU720, Brea, CA) 
3.3.2 Cell Culture 
Human colorectal tumor cells (HCT-116, ATCC, Manassas, VA) were seeded in 
T25 flasks with cell culture media composed of McCoy’s Modified Medium (Corning 
CellGro, Corning, NY) supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin-streptomycin-amphotericin B (Lonza, Basel, Switzerland) at 37°C with 5% 
CO2. After the cells reached confluence, we detached the cells with 0.5% trypsin solution 
(Thermo Scientific HyClone, Waltham, MA) and centrifuged at 600 RPM for 5 minutes. 
For TPM imaging, seeded into 12 well plates with coverslips placed in each well and for 
photothermal therapy, cells were seeded into 96 well plates. After reaching ~90% percent 
confluence, we incubated GNRs in fresh culture medium at 0.5 optical density (OD) with 
the cells.  
3.3.3 Two-Photon Imaging 
For TPM imaging, depending on exposure time, we removed the GNR media 
after 1.5 hours and let the cells incubate further in fresh media for varied exposure times 
to allow for the cellular internalization processes to occur. We allowed the cells incubate 
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further for 0, 1.5, 4.5, 10.5 and 22.5 hours for a total of 1.5, 3, 6, 12 and 24 hours post-
GNR exposure. After GNR incubation, we removed the media and washed three times 
with PBS and fixed the cells in 4% paraformaldehyde (PFA, Fisher Scientific, Waltham, 
MA) for 10 minutes. After fixation, we washed with PBS three times and stained the cells 
with a plasma membrane stain (CellMask, Life Technologies, Carlsbad, CA) for 20 
minutes and washed again with PBS three times. Then we removed the coverslip from 
the bottom of the well and mounted it on a glass slide with Vectashield mounting 
medium (Vector Laboratories, Burlingame, CA) and sealed it with nail polish. Imaging 
was performed under a TPM (Prairie Technologies, Middleton, WI) with an ultrafast 
pulsed femtosecond tunable Ti:Sapphire laser (Spectra Physics Mai-Tai, Irvine, CA). The 
laser was tuned to 800 nm to image the gold nanorods and 750 nm to image the plasma 
membrane stain. To image the emitted light, we used photomultiplier tubes (PMTs) with 
a 660 nm +/- 20 nm bandpass filter for the gold nanorods (Channel 1) and 595 nm +/- 50 
nm bandpass filter for the plasma membrane stain (Channel 2). The cells were imaged 
with a water-immersion 60x objective (Olympus) with a 1.0 NA allowing for a high 
resolution and high magnification. All images were taken with the proprietary software 
(PrairieView) and analyzed with ImageJ (NIH, Bethesda, MD). 
3.3.4 Photothermal Therapy 
For photothermal therapy fluence rate threshold experiments we incubated the 
GNR with cell culture medium for the full 1.5, 3, 6, 12, and 24 hours before performing 
the experiments. Then, we irradiated the cells with an 808 nm CW diode laser, focused to 
a spot size of 0.16 µm diameter, for five minutes at different fluence rates, ranging from 
20-50 W/cm
2
. During irradiation, we placed the 96 well plates on a heated plate to keep 




assess damage, we used Trypan Blue which is a visible light stain that is excluded from 
live, viable cells and allowed into cells with membrane damage, which indicates necrotic 
cell death. To allow for all death processes to occur, we waited 24 hours after laser 
irradiation and stained the cells with Trypan Blue for 5 minutes and washed with PBS 3 
times. Then we imaged the cells under a bright-field microscope to evaluate the damage. 
3.3.5 Flow Cytometry 
To probe cell death pathway initiation after photothermal therapy we incubated 
the GNRs in a similar method as for TPM imaging, removing the GNR media after 1.5 
hours and let the cells incubate further in fresh media for varied exposure times (namely 
0, 4.5 and 22.5 hours post-GNR incubation) to allow for the cellular internalization 
processes to occur. To analyze the cell death pathways, we stained for apoptosis and 
necrosis using the Vybrant Apoptosis Assay Kit #4 (Life Technologies) including YO-
PRO-1 (YP, 491/509 nm) and Propidium Iodide (PI, 535/617 nm). YP is able to pass 
through the slightly permeable membrane in apoptotic cells and emits a moderate 
fluorescence whereas PI can only stain cells with compromised membrane integrity 
indicating necrosis. One hour after photothermal therapy, we washed, trypsinized, 
centrifuged the cells in microcentrifuge tubes, and then stained the cells with a solution 
containing YP and PI for 30 minutes on ice. We chose one hour after photothermal 
treatment because of a study showing that apoptosis and necrosis measurements depend 
on time after cell injury, in which the authors found that the apoptotic maximum was 
approximately one hour after treatment (158). As a control, we stained cells with no 
external effects (negative control), cells exposed to 1 hour of UV radiation (apoptotic 
positive control) and cells exposed to 30 minutes of lysis buffer (Promega, Madison, WI). 
To quantitatively measure the YP and PI fluorescence we used a flow cytometer (BD 
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Accuri C6, Franklin Lakes, NJ) with PMTs and bandpass filters at 530 nm +/- 15 nm 
(FL1) for YP and >670 nm (FL3) for PI. Cells that are alive have low amounts of YP or 
PI fluorescence. Apoptotic cells have only moderate YP fluorescence and necrotic cells 
have high YP and PI fluorescence. 
3.4 RESULTS 
3.4.1 Gold Nanorod Characterization 
We first characterized the GNRs using TEM to determine the size and UV-Vis to 
measure the spectra to confirm that these GNRs were optimal for cellular delivery, 
imaging, and photothermal therapy. Analyzing TEM images (inset of Figure 12) with 
ImageJ, we measured the size of the GNRs to be approximately 47 nm in length and 15 
nm in width. As shown in the absorbance plot (Figure 12) the transverse SPR frequency 
stayed constant around 530 nm and we tuned the longitudinal peak SPR frequency to a 
sharp peak located around 780 nm, by modifying the aspect ratio to approximately 3. 
 
 
Figure 12:  Absorption spectra for fabricated gold nanorods. Inset: TEM 
image of fabricated gold nanorods 
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3.4.2 Gold Nanorod Localization 
Next, we determined the localization of the GNRs in cancerous cells after 
different durations. To do this, we imaged the cells using TPM after incubation with 0.5 
OD GNRs for a range of times: 1.5, 3, 6, 12, and 24 hours. We found that the 
concentration correlated to 0.5 OD was ideal because there was no apparent cytotoxicity 
within 96 hours of incubation yet it was sufficient to induce photothermal damage. TPM 
is optimal because of its thin optical sectioning, which allows us to image above the cell, 
within the cell and below the cell to accurately define the GNR location. We found that 
the GNRs were found in different cellular regions at the different time points as the 
cellular internalization process advanced.  
In Figure 13, we show three slices for each significant time point from a TPM Z-
stack going through the cells. The Z-stack consists of a slice at the top (1) of the cell, 
within (2) the cell and at the bottom (3) of the cell. The Channel 1 PMT, colored as red, 
detected the GNRs primarily, and the Channel 2 PMT, colored as green, detected the cell 
membrane stain. At the 1.5 hour time point, the GNRs were observed to start to bind and 
accumulate on the cell membrane (Figure 13). After 3 hours of GNR incubation, we 
found the GNRs to be mainly accumulated on cell membrane similar to the 1.5 hour time 
point, but at a higher GNR volume. Internalization was more prominent after 6 hours 
(Figure 13) of GNR incubation with GNRs starting to aggregate inside the cell close to 
the cell membrane, most likely in lysosomes. At 12 hours (Figure 13) after incubation, 
the GNRs were fully internalized in cells and appeared to be not as aggregated, spread 
throughout the cell, possibly escaping from lysosomes. Finally, at the 24 hour time point 
(Figure 13), the GNRs seem to be accumulating near organelles within the cellular 
perinuclear region, possibly nuclei or mitochondria. 
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Figure 13:  GNR Internalization. All sets show three images through the cell: left is the 
directly above the cells, middle is 4 µm to visualize inside the cell, right is 4 
µm more to directly below the cell. The 1.5 hr incubated GNRs (red) were 
bound to the top, sides and bottom of cells (green, cell membrane). The 6 hr 
incubated GNRs were internalized into lysosomes within the cell. The 
GNRs were escaping from lysosomes into the cytoplasm at 12 hour GNR 
incubation. The final set shows GNRs internalized within the cell and 
accumulation in the perinuclear area near specific organelles after 24 hour 
GNR incubation 
 62 
3.4.3 Gold Nanorod-Mediated Photothermal Threshold Determination 
After determining the cellular location of GNRs at the specific time points, we 
performed photothermal therapy on the samples. To determine the fluence rate threshold, 
we conducted several rounds of experimentation, increasing the fluence rate (by 2.5 
W/cm
2
) until we detected signs 
of cell death using Trypan blue 
and bright-field imaging. This 
process is demonstrated in 
Figure 14 with a below fluence 
rate threshold image showing no 
cell death and at fluence rate 
threshold image, we can clearly 
perceive cell death. As controls, 
we incubated (1) cells with GNRs 
for 24 hours and irradiated (2) cells 
without GNRs with the NIR laser 
at 50 W/cm
2
, both of which were shown not to induce cell death. We found that the 









 and 37.5 W/cm
2
, respectively (Figure 15). The fluence rate 
thresholds were confirmed with three experimental replicates to show that each threshold 
was significantly different from the other time points. Therefore, we determined that the 
fluence rate threshold for damage decreases with increasing incubation time, as can be 
seen in Figure 15, which indicates a threshold dependence on GNR cellular localization. 
 
Figure 14:  Cell Death Threshold. Showing that 
below the threshold at 1.5 and 24 hour 
GNR incubation points there is no cell 
death with Trypan blue but at the 




Figure 15:  Cell Death Threshold dependence on GNR localization. The fluence rate at 
which cell death starts to occur depends on the GNR incubation time, which 
is shown to be directly proportional to the GNR localization  
3.4.4 Quantitative Analysis of Cell Death Pathways 
Next, after showing that the cell death is influenced by GNR cellular localization 
with Trypan blue staining, we quantitatively analyzed the cell death pathway response to 
GNR-mediated photothermal therapy using flow cytometry. For this experiment, we 
removed the GNRs after 1.5 hours incubation and let the cells incubate the rest of the 
exposure time (0, 4.5 and 22.5 hours post-GNR incubation) to allow for the cellular 
internalization processes to occur. We chose those time points, because they were 
significantly different in terms of GNR localization: membrane-bound (1.5 hours), 
aggregated in lysosomes (6 hours) and localized in the perinuclear region (24 hours). The 
extra step of removing GNRs after 1.5 hours of incubation was performed to avoid 
possible influences on threshold from final concentration differences in the cell after the 
GNR incubation. We performed flow cytometry on the cell samples after photothermal 
therapy to obtain quantitative values for the number of apoptotic and necrotic cells, and 
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we obtained log-log plots (Figure 16) with the apoptotic stain intensity on the x-axis and 
the necrotic stain intensity on the y-axis.  
 
Figure 16:  Flow Cytometry region determination. Log-log plot of fluorescence 
intensity, apoptosis stain (YP) on the x-axis and necrosis stain (PI) on the y-
axis, (A) shows the negative control of only cells stained. (B) shows the 
necrotic positive control to determine the necrotic region. (C) shows the 
apoptotic positive control to determine the live, apoptotic and necrotic 
regions. (D) Representative sample of cells incubated with GNRs for 6 
hours and exposed to 40 W/cm
2
 irradiation. 
After gating out the debris, we are left with three distinct regions, which are 
indicative of live cells, apoptotic cells and necrotic cells. To determine the three different 
cell regions, we performed control experiments using just stained cells (negative control), 
cells exposed to 1 hour of UV radiation (apoptotic positive control), and cells lysed with 
lysis buffer (necrotic positive control), as shown in Figure 16A, B and C respectively. 
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After determining the regions, we analyzed the cell samples after photothermal therapy 
and determined the percentage of cells (of the total in all three regions) for live, necrotic 
and apoptotic cells. These values were averaged over three replicates for 1.5, 6 and 24 
hour time points over several fluence rates (35-50 W/cm
2
) and compared to each other in 
bar plots (Figure 17).  
From Figure 17 it is clear to see that the necrotic threshold (~50%) is highest for 
the shortest time point as was shown in the previous experiment. The necrotic threshold 
for the 1.5 hour time point was 50 W/cm
2
 (close to the 47.5 W/cm
2
 threshold for the 
previous experiment), the 6 hour was 47.5 W/cm
2
 and the 24 hour was 42.5 W/cm
2
. 
However, the apoptotic percentage was significantly less than the necrotic percentages. 
Apoptosis thresholds followed a similar trend as the necrotic thresholds, as the longer 
incubation times had a lower apoptotic fluence rate threshold. Furthermore, the longer 
incubation times had the higher apoptotic percentages at the threshold, ~18.5% for 24 
hour incubation time at 37.5 W/cm
2
 (~3x the control), ~13% for 6 hour incubation time at 
40 W/cm
2
 (~2x the control), and ~9.2% for 1.5 hour incubation time at 42.5 W/cm
2
 
(~1.5x the control). 
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Figure 17:  Quantitative Analysis of Cell Death Response to Photothermal Therapy. In 
(A) we see the 24 hour incubated GNRs live, necrotic and apoptotic 
percentages for several fluence rates and see the trends. In (B), (C), (D) we 
see the live, necrotic, and apoptotic cell percentages respectively with all 
three GNR incubation times compared together at several fluence rates. 
3.5 DISCUSSION 
3.5.1 Gold Nanorod Characterization 
We successfully fabricated GNRs with CTAB on the surface and a size of 47 x 15 
nm, measured by TEM image analysis. Thus, the peak SPR frequency was turned to 780 
nm, which was sufficient for inducing photothermal damage and TPM imaging (Figure 
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12). All experiments utilized GNRs diluted to 0.5 OD at 808 nm for optimal absorption 
of the diode laser for photothermal therapy and comparison purposes. 
3.5.2 Gold Nanorod Localization 
Using two-photon imaging, we were able to determine the localization of the 
GNRs at several different time points. Our hypothesis that the GNRs would be found in 
different regions of the cell as the cellular internalization process progressed in time was 
shown to be correct. We believe this is due to CTAB on the surface, because it a cationic 
surfactant. Since the cells are negatively charged and the membrane is composed of 
lipids, the CTAB positive charge and lipophilic nature will be attracted to the cellular 
membrane, which is shown to start at the 1.5 hour time point and continue on at the 3 
hour time point (Figure 13). The cell membrane allows the CTAB GNRs to transport 
through the membrane into the cell, possibly into lysosomes due to the positive charge, 
which starts in the 3 hour time point, but is more noticeable at the 6 hour time point 
(Figure 13). In fact, the GNRs at the 6 hour time point look to be aggregated and in small 
compartments, which seem to lysosomes. After the 6 hour time point we believe that the 
GNRs escape from the lysosome and the surface CTAB would attract the GNRs to 
organelles within the cell with lipid membranes, such as the nuclei and mitochondria (72, 
155). The plasma membrane stain that we use is also lipophilic and when internalized 
will also localize to organelles within the cell with lipid membranes. In the 24 time 
points, the GNRs appear to be localized to the perinuclear region where the cell 
membrane stain is located within the cell, which we believe to be near mitochondria or 
nuclei (Figure 13). 
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3.5.3 Gold Nanorod Photothermal Threshold Determination 
By visually inspecting the thresholds at which cell death was determined for 
different GNR incubation times (Figure 15) clearly indicates that photothermal therapy 
depends on incubation time, which is correlated with the localization. The fluence rate 
difference between the 1.5 hour and 24 hour GNR incubation is 10 W/cm
2
, which is 
significant compared to the 2.5 W/cm
2
 step size in determining the threshold over four 
replicates. As a result, we believe that inducing cell damage through GNR-mediated 
photothermal therapy is influenced by GNR localization. However, we believe that it is 
possible that this result could be skewed with the final GNR concentration varying 
between the different time-points. We believe this may occur because the longer GNR 
incubation times leads to a longer cellular exposure to the GNRs and consequently more 
GNRs could be taken up by the cells. Therefore, based on other studies and this work, we 
believe that the final GNR concentration in the cells could be an issue that has not been 
explored (72, 73). Subsequently, for the cell death pathway experiments we incubated the 
GNRs for only 1.5 hours (the smallest time point), then removed the media and allowed 
the cells to incubate in fresh media for the remainder of the time point. By following this 
procedure, we were assured that the concentration would be the same for all time points. 
3.5.4 Quantitative Analysis of Cell Death Pathways 
To illustrate a more accurate understanding of the cell death pathway response to 
photothermal therapy we obtained quantitative values of the number of apoptotic, 
necrotic and live cells (Figure 17). The live cell percentage decreases consistently, for all 
incubation times, as the fluence rate increases with cell death produced by different ratios 
of necrosis and apoptosis. Consequently, necrosis increases, for all incubation times, with 
fluence rate increases. After the necrotic threshold, defined as the fluence rate when the 
necrosis percentage is greater than 50%, necrosis is the dominant cell death pathway. As 
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shown in Figure 17, the 24 hour time point, internalized GNRs localized to organelles, 
has the lowest fluence rate at the necrotic threshold and the 1.5 hour time point, 
membrane-bound GNRs, has the highest fluence rate at the threshold.  
This result is contrary to the study performed by Wei and coworkers; however, we 
believe that the differences in the experiment, that we use a CW laser and that we have a 
quantitative measurement of the amount of necrotic cell death, can explain these 
differences (72). The authors used a pulsed laser in CW mode, which involves a scan of 
laser pulses over a larger area with approximately 0.126 ms exposure for each nanorod. 
This is a quasi-CW mode, at the equivalent of millisecond pulses at each point, and could 
induce photodestructive effects instead of only thermal effects due to the extremely small 
GNP relaxation time (~0.6 ns) (81). Secondly, the authors assessed cell death 
subjectively using qualitative measures such as imaging the ethidium bromide stain and 
visually inspecting for membrane blebbing, which the authors state indicates necrosis but 
as discussed in Chapter 1, is actually representative of both necrosis and apoptosis. 
Qualitative measures for detecting cell death were also used by El-Sayed and coworkers 
when demonstrating that cytoplasmic gold nanoparticles required less energy to induce 
cell death than nuclear localized gold nanoparticles (73). We believe the heating profile 
of the internalized GNRs can induce cell death at lower fluence rates because the thermal 
energy is localized and spreads evenly throughout the cell to induce cell death through 
other mechanisms than just membrane lysis, such as the perturbation of the nuclei or 
mitochondria.   
We found that for all time points there was a common trend for the apoptotic 
percentages. Essentially, the apoptotic percentage increased to a maximum value and 
decreased at or before reaching the fluence rate at the necrotic threshold. This indicates 
that there is an apoptotic threshold at which apoptosis and necrosis have approximately 
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equal contributions to cell death, which is consistently at a lower fluence rate than the 
necrotic threshold. When the necrotic threshold power is reached, necrosis becomes the 
dominant cell death pathway with a reduction in the number of apoptotic cells. We 
observed the maximum apoptotic percentage with the 24 hour incubated GNRs, around 
3  the control, which we believe is because the GNRs were localized to the 
nuclei/mitochondria, due to their influence on the apoptotic pathway (155). The 1.5 hour 
time point had the lowest amount of apoptosis, which we believe is due to the membrane 
localization where the heating would elicit membrane damage and induce necrosis. 
Therefore, we also demonstrated that the initiation of apoptosis is affected by GNR 
localization during photothermal therapy. 
3.5.5 Comparison to Relevant Work  
In our study, we found the apoptotic percentage to be lower than the necrotic 
percentage, but it is significantly increased from the control, 1.5  for 1.5 hour, 2  for 6 
hour, and 3  for 24 hour time points. In cancer, the apoptotic pathway is inhibited such 
that unregulated proliferation can occur, which may cause resistance to apoptosis in 
certain cancer types. Therefore, several previous studies have also explored the 
effectiveness of these anti-cancer therapeutics with different cancer types that may be 
resistant or augmented with processes that attempt to normalize the cell apoptotic 
pathway. However, studies have performed flow cytometry to measure apoptotic 
percentage with anti-cancer therapeutics, such as doxorubicin, tumor necrosis factor-
related apoptosis inducing ligand (TRAIL), CD95, and non-steroidal anti-inflammatory 
drugs, These studies have observed induced apoptosis percentages for these anti-cancer 
drugs and therapeutics ranged from 10-40% depending on the effectiveness of the 
therapeutic to the specific cell type (121-124). Therefore in comparison to our study, we 
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see that the apoptosis 6 and 24 time points, ~13% and ~18.5% respectively with colon 
cancer cells, are in the range seen for anti-cancer therapeutics, which could even vary for 
different cell types. We believe that this indicates that for GNR-mediated photothermal 
therapy at those time-points and at fluence rates at the apoptotic maximum, we can 
achieve a similar anti-cancer therapeutic effect. If total cell death was the goal of a study, 
without specifically desiring apoptosis or necrosis, the optimal parameters for 
photothermal therapy would be the fluence rate with the highest cell death. However, our 
goal was to induce apoptosis as a significant portion of the cell death. Therefore, we can 
consider these points as the optimal parameters for GNR-mediated photothermal therapy 
for limiting the extracellular damage in terms of having maximum apoptosis with also 
causing significant cell death. 
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Chapter 4: Cell Death Pathways Initiated during Gold Nanorod-
mediated Photothermal Therapy in 3D Multicellular Tumor Spheroids 
4.1 INTRODUCTION 
In continuing this extensive study, we quantitatively analyzed the cell death 
response to GNR-mediated photothermal therapy assessed in MTS as an in vitro tumor 
model with two different GNR delivery methods. Using the agarose-coated 96 well plate 
method, the colon cancer cells were forced to aggregate to each other and form MTS. 
GNRs were delivered to the MTS in two different ways: (1) co-incubated with the MTS 
at the time of inception, which we projected to form a uniform distribution, and (2) 
incubated for 24 hours for a distribution representative of in vivo photothermal studies, 
which we anticipated to only be localized in the MTS periphery. After PTT irradiation, 
we quantitatively analyzed MTS cell response for apoptosis and necrosis using flow 
cytometry. We expected that apoptosis and necrosis percentages will be higher for the 
uniform GNR distribution. However, due to the coupling and enhanced absorption effect 
of aggregated GNRs limited only to the periphery, we observed that the necrotic and 
apoptotic damage threshold was lower for the 24 hour incubated GNRs than the co-
incubated GNRs. Furthermore, in comparison to 2D monolayer quantitative analysis 
studies of cell death response to photothermal therapy performed earlier, we found that 
there is overall less cell death, both apoptosis and necrosis, in MTS than the 2D 
monolayer due to increased cell-cell and cell-ECM interactions. This study aims to show 
that 3D cell culture, MTS, is an advantageous model for analytically understanding the 
cell death response to GNR-mediated photothermal therapy. 
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4.2 RELEVANT WORK 
Several groups recently have investigated nanoparticle interactions with MTS, 
primarily studying the nanoparticle penetration with varied conditions. Similarly, few 
groups have modeled the nanoparticle diffusion and penetration in MTS (137, 159).  One 
group explored the uptake enhancement of polystyrene nanoparticles in MTS conjugated 
with collegenase to degrade ECM proteins, which allowed to particles to travel further 
into the MTS rather than just the MTS margin with the unconjugated nanoparticles (140). 
Another study explored the dependence of size on ultrasmall gold nanoparticle (2-15 nm) 
penetration into MTS. The authors found that the smaller nanoparticles (2 nm) were more 
evenly distributed throughout the MTS and were internalized into the cells more than the 
larger nanoparticles, which were mostly located in the MTS edge (15 nm) (160). Several 
papers have also explored encapsulating drugs into synthetic micelles and finding that the 
therapeutic effect was limited by penetration ability of the drugs and micelles, similar to 
our study (161, 162). 
The cell death pathway response to known toxic nanoparticles, (1) CdTe and (2) 
CTAB gold nanoparticles has been explored with 2D and 3D cell culture (158). The 
authors demonstrated that the nanoparticle toxicity to 3D cell culture was substantially 
less than with 2D monolayers for both necrosis and apoptosis, as was seen in our study, 
conceivably because of the limited penetration of the nanoparticles as well as the cell-cell 
and cell-ECM interactions increasing cell repair function. Furthermore, the authors 
observed that, after exposure to the nanoparticles, apoptosis and necrosis values changed 
dramatically with time as cells moved from apoptosis to secondary necrosis. As a result 
of this study, we have performed all quantitative experiments at 1 hour after laser 
exposure to match the observed peak of apoptosis detection in that experiment.   
 74 
Two different groups have studied gold nanoshell-loaded tumor associated 
macrophage MTS penetration and photothermal therapy (163, 164). Using breast cancer 
MTS as a hypoxic tumor model, the authors showed that nanoshell-loaded macrophages 
penetrated into the MTS periphery and, after laser irradiation, imaged cell death only near 
the nanoshell-loaded macrophages localization in the MTS (164). The other group used 
nanoshell-loaded macrophages, due to their ability to pass through the blood-brain 
barrier, to treat a glioma MTS model. The authors created two glioma MTS models: 
similar to the first study, a normal (1) MTS containing glioma cells and the macrophages 
infiltrated into the periphery, and (2) hybrid, which mixed nanoshell-loaded macrophages 
within the MTS with the glioma cells to simulate a uniform distribution, similar to our 
co-incubated MTS model. Using a continuous wave laser at a single fluence rate, the 
authors found that for both the hybrid and infiltrated MTS, they could completely 
suppress growth and visualized significant cell death (163).  
Another group examined the surface chemistry-dependent GNR penetration and 
photothermal therapy of MTS (165). The authors found that positively-charged GNRs 
accumulated more in the MTS, but the negatively-charged GNRs penetrated further into 
the MTS. In our study, we use positively-charged GNRs due to the residual CTAB on the 
GNR surface. After photothermal therapy, the authors measured the cell death, using acid 
phosphatase assay, and found that the negatively-charged GNRs had more cell death per 
particle than the positively-charged particles, most likely due to the deeper penetration. 
4.3 MATERIALS AND METHODS: 
4.3.1 Multicellular Tumor Spheroid Formation 
Human colorectal tumor cells (HCT-116, ATCC, Manassas, VA) were seeded in 
T25 flasks with cell culture media composed of McCoy’s Modified Medium (Corning 
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CellGro, Corning, NY) supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin-streptomycin-amphotericin B (Lonza, Basel, Switzerland) at 37°C with 5% 
CO2. After the cells reached confluence, we detached the cells with 0.5% trypsin solution 
(Thermo Scientific HyClone, Waltham, MA) and centrifuged at 600 RPM for 5 minutes. 
For MTS formation, we seeded 1500 cells per well into agarose-coated 96-well plates as 
reported by Friedrich et al, replacing the cell culture media every 3-4 days (130). The 96-
well plate is coated with 1.5% sterilized agarose type III (Sigma Aldrich, St. Louis, MO) 
to provide a non-adherent surface forcing the cells to aggregate into the center of each 
well, and was incubated in a humidified atmosphere with 5% CO2 at 37°C after being 
sealed with plastic paraffin film (Parafilm, Bemis Flexible Packaging, Neenah, WI). To 
determine size and integrity, we visually inspected the MTS daily under a bright-field 
microscope and took images. 
4.3.2 Gold Nanorod Synthesis 
We followed the same gold nanorod synthesis as previously done by Nikoobakht 
et al and Jana et al in a Ag(I) –assisted growth method (145, 157). Briefly, we made an 
aqueous gold seed particle solution is prepared by adding 250 µL of 0.01 M HAuCl4 
(Sigma Aldrich, St. Louis, MO)  to 9.75 mL of aqueous 0.1 M cetyl trimethylammonium 
bromide (CTAB, Sigma Aldrich, St. Louis, MO) solution in a vial, while stirring. Then 
we made a 0.01 M NaBH4 (CTAB, Sigma Aldrich, St. Louis, MO) solution by placing DI 
water in a vial, equilibrating it in an ice bath, adding the NaBH4, and mixing it rapidly. 
600 µL of the aqueous 0.01 M NaBH4 is added to the gold seed particle solution and 
stirred for 2 min. Next, an aqueous growth solution is prepared by combining 9.5 mL of 
0.1 M CTAB, 75 µL of 0.01 M AgNO3 (Sigma Aldrich, St. Louis, MO), 500 µL of 0.01 
M HAuCl4, and 55 µL of 0.1 M ascorbic acid (Sigma Aldrich, St. Louis, MO) in a 15 mL 
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centrifuge tube.  Upon adding ascorbic acid, we inverted the tube two times to mix, and 
the solution became colorless due to partial reduction of the gold salts.  12 µL of the gold 
seed solution was then added to this growth solution followed by slowly inverting it two 
times to mix, and it was incubated at 27 °C overnight without stirring. The resulting GNR 
solution was centrifuged three times at 8000 RPM for 20 minutes to remove excess 
CTAB, which would cause cytotoxicity if left in solution, and concentrated the solution 
in 15 mL of DI H2O. We measured the dimensions by averaging over 300 individual 
particles analyzed in ImageJ (NIH Bethesda, MD) using transmission electron 
microscopy (TEM, FEI Tecnai, Hillsboro, OR) images (inset of Figure 18), which were 
measured to be 47 x 15 nm. We measured the optical density (OD) or absorbance of the 
solution using a UV-Vis Spectrophotometer (Beckman Coulter DU720, Brea, CA) as 
shown in Figure 18. 
 
Figure 18:  Absorption spectra for fabricated gold nanorods. Inset: TEM image of 
fabricated gold nanorods 
4.3.3 GNR Delivery Techniques 
We used two different delivery techniques: co-incubation and 24 hour incubation. 
During co-incubation, the GNRs are seeded simultaneously with the HCT-116 cells at the 
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beginning of MTS formation and allowed to incubate with the cells as the MTS grows. 
For 24 hour incubation, the GNRs were incubated for 24 hours with the spheroids on day 
6 of growth, due to it best mimicking in vivo tumors at this time-point (as discussed in a 
later section). For both delivery techniques the GNRs are incubated with spheroids at 
0.05 OD mixed with fresh cell culture medium, which was found to be a non-toxic 
concentration. 
4.3.4 Two-Photon Imaging for GNR distribution 
After incubating the GNRs with the MTS in two different techniques, we utilized 
TPM to determine the GNR distribution. To prepare for staining, we removed the GNR 
media from each well and washed with PBS (phosphate buffered saline) to ensure no 
residual GNR binding, and fixed the MTS in 4% paraformaldehyde (PFA, Sigma 
Aldrich, St. Louis, MO) for 10 minutes. Then we stained the MTS with the CellMask 
plasma membrane stain (Life Technologies, Carlsbad, CA) for one hour, to allow for 
MTS stain penetration for visualizing the MTS and understanding where the GNRs reside 
with respect to the cellular matrix. Then we mounted the MTS onto concave slides with 
Vectashield (Vector Laboratories, Burlingame, CA), which were sealed with nail polish. 
Imaging was performed with TPM (Prairie Technologies, Middleton, WI) utilzing 
an ultrafast pulsed femtosecond tunable Ti:Sapphire laser (Spectra Physics Mai-Tai, 
Irvine, CA). The laser excitation was tuned to 750 nm, to detect the plasma membrane 
stain, and 800 nm, to detect the GNRs. For detecting the emitted light, photomultiplier 
tubes (PMTs) were used with a 660 nm +/- 20 nm bandpass emission filter for the gold 
nanorods (Channel 1) and 595 nm +/- 50 nm bandpass emission filter for the plasma 
membrane stain (Channel 2). The cells were imaged with a water-immersion 20x and 60x 
objectives (Olympus) with 1.0 NA allowing for a high resolution and high magnification. 
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We obtained single images and Z-stacks by imaging through the MTS in 10 µm 
increments, all of which were taken with the proprietary software (PrairieView) and 
analyzed using ImageJ (NIH, Bethesda, MD). 
4.3.5 Photothermal Therapy 
For the photothermal therapy experiments, the MTS were washed with PBS after 
removing the GNRs for each respective delivery technique. Then we irradiated the MTS 
with an 808 nm CW diode laser for 5 minute duration. The fiber-coupled laser was 
focused to a spot size of 1.6 mm diameter using a series of biconvex and aspherical 
lenses. The laser fluence rate ranged from 30-50 W/cm
2
, increasing in increments of 5 
W/cm
2
, to quantitatively determine the threshold at which cell necrosis and apoptosis 
occurs. After photothermal therapy is done, the MTS are prepared for flow cytometry. 
4.3.6 Flow Cytometry 
To quantitatively analyze cell death pathway response to photothermal therapy we 
use flow cytometry one hour after laser irradiation, due to apoptosis being a time-
dependent process and achieving its maximum at that time-point (158). We broke down 
the MTS ECM by adding 0.5% trypsin to the MTS for 15-20 minutes, and pelleted the 
MTS cells by centrifuging at 600 rpm for 5 minutes. Then we replaced the supernatant 
with the staining solution composed of YO-PRO-1 (YP, Life Technologies) and 
propidium iodide (PI) and incubated for 30 minutes on ice. YP is a carbocyanine nucleic 
acid stain that can permeate into apoptotic cells, while propidium iodide can permeate 
into any cell with membrane damage, namely necrotic cells. To quantitatively measure 
the YP and PI fluorescence we used a flow cytometer (BD Accuri C6, Franklin Lakes, 
NJ) with PMTs utilizing a bandpass emission filter at 530 nm +/- 15 nm (FL1) for YP 
and long-pass emission filter at 670 nm (FL3) for PI. The cells are sorted according to 
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their fluorescence profile. Cells that are alive have low amounts of YP or PI fluorescence. 
Apoptotic cells have only moderate YP fluorescence and necrotic cells have high YP and 
PI fluorescence. The disparity between necrotic and apoptotic cells is compared between 
co-incubated GNR MTS, 24 hour incubated MTS, positive and negative controls. As a 
control, we used stained cells with no external factors (negative control), cells exposed to 
1 hour of UV radiation (apoptotic positive control) and cells exposed to 30 minutes of 
lysis buffer (Promega, Madison, WI).  
4.4 RESULTS: 
4.4.1 Multicellular Tumor Spheroid Growth Analysis 
In this study, we successfully formed MTS using the agarose-coated 96 well plate 
method as described earlier. We analyzed the MTS by taking bright-field images and 
measured the diameter every 24 hours until the MTS growth stalled, which was around 
day 20 (Figure 19). The inset of Figure 19 shows the bright-field images over several 
days to show cell aggregation and MTS growth. MTS have different three different 
regions of growth: (1) exponential growth (day 3-5 after seeding), (2) linear growth (day 
6-15), and (3) stalled growth (plateau region seen in days 16-21), which is seen in Figure 
19 (130). Based on the MTS growth curve, we chose day 6 for experimentation because 
of its location in the linear region. 
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Figure 19:  MTS growth curve. Measured MTS diameter increasing over time through 
three different regions: (1) from day 3-5 in the exponential region, (2) from 
day 6-15 in the linear region, and (3) from day 16-21in the plateau region. 
Inset shows MTS images from Day 3, Day 6, Day 9 and Day 12. 
4.4.2 Gold Nanorod Penetration in Multicellular Tumor Spheroids 
Subsequently, we incubated GNRs with the MTS using the two different delivery 
methods and performed TPM imaging to determine GNR penetration and uptake. Figure 
20 is composed of TPM slices at the top (   ), upper half, bottom half and bottom  of 
the MTS to illustrate the GNR penetration (red) in the MTS, stained with a cell 
membrane stain (green), GNRs incubated for 24 hours (Figure 20A) are only found in the 
MTS periphery as expected. In the first slice (Figure 20A) the GNRs are spread out since 
the whole MTS top area is exposed to the GNRs in media; however, as we imaged into 
the MTS the GNRs appear to only be in the outer edges. Therefore, it is apparent that the 
GNRs do not penetrate deep into the MTS. In Figure 20B, we see a representative MTS 





 slices (Figure 20B), the co-incubated GNRs are unmistakably further than in the 




Figure 20:  MTS Slices showing GNR Distribution. For both sets, we have 4 images 
going through the spheroid in the z-direction, showing the top, two images 
in the middle and bottom of the MTS. In (A), we see the 24 hour incubated 
24 hours are localized to only the MTS periphery. In (B), the co-incubated 
are shown to be distributed somewhat uniformly through the MTS. 
Next, we quantitatively analyzed the images to determine the respective 
penetrations for the two GNR delivery methods. Images taken with the TPM GNR 
channel were thresholded to allow only GNRs to be visible and analyzed (Figure 21). To 
analyze the penetration, we divided the MTS into 5 concentric rings separated using 
segments equivalent to 20% of the total radius and counted the accumulation in each 
region. GNRs incubated for 24 hours (Figure 21A) are distinctly found only in the outer 
ring, limited to the first 20% of the MTS radii. The co-incubated GNR distribution is 




Figure 21:  GNR Penetration in MTS. Thresholded images of GNR images showing the 
penetration into different MTS regions divided by 20% radii segments. For 
(A), we see that the 24 hour incubated GNRs are found primarily in the first 
20% segment. For (B) the co-incubated GNRs are found distributed 
throughout the MTS. 
Moreover, we plotted (Figure 22) the percentage of total GNRs in each ring 
normalized to their respective ring area due to outer rings being larger than the inner 
rings. In Figure 22, we see that the 24 hour incubated GNRs are only found in the first 
20% of the MTS. Conversely, the co-incubated GNRs accumulated slightly higher in the 
first 20% of the MTS but are relatively evenly distributed within the ensuing four 
regions. Thus, this shows that the two GNR delivery techniques have statistical 
differences (p < 0.01) in MTS distribution, which are clearly seen in the quantitative 




Figure 22: Quantification of GNR penetration per MTS Area Region. Using the 
thresholded image, we determine the GNR intensity values for each MTS 
region divided by the total GNR intensity values to obtain GNR penetration 
percentage normalized by the total MTS region area. We see the 24 hour 
incubated GNRs are only located in the first 20% of the MTS, whereas the 
co-incubated GNRs are found to be distributed throughout the MTS. 
4.4.3 Gold Nanorod Localization in Multicellular Tumor Spheroids 
Taking advantage of the high axial and lateral resolution of TPM, we desired to 
determine the locations of the GNRs on the cellular level. Figure 23A and B are high 
magnification images of the co-incubated GNRs (red) close to the center of the MTS. The 
GNRs are seen to be distributed throughout and highly aggregated but mostly found in 
the ECM between cells, however, in Figure 23B when we magnify even further GNRs 
are shown to be internalized in some cells. The 24 hour incubated GNRs (Figure 23C and 
D) show GNRs located near the MTS periphery. The GNRs seem to be less aggregated in 
clumps, probably due to the shorter incubation time. In addition, the GNRs appear to be 
both internalized and distributed in the ECM evenly, such that there is more 




Figure 23:  High Magnification images of GNR uptake in cells. We show co-incubated 
GNRs (A and B) and 24 hour incubated GNRs (C and D). Most co- 
incubated GNRs are found in the ECM and with the 24 hour incubated the 
GNRs appear to be evenly distributed between being found in the ECM and 
internalized in cells. 
4.4.4 Gold Nanorod-Mediated Photothermal Therapy of Multicellular Tumor 
Spheroids 
After observing the GNR locations of the two delivery techniques, we performed 
photothermal therapy on the GNR-incubated MTS. To visualize MTS damage during 
photothermal therapy we took bright-field images one day before and one day after laser 
irradiation (Figure 24).  As compared to normal growth in Figure 19, the MTS was 
completely destroyed at 40 W/cm
2
 for both GNR delivery methods, 24 hour incubated 
GNRs and the co-incubated GNRs. We observed that the MTS has become less dense, 
lost structural integrity and the cells seem to spread throughout the well. Since the cells 
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start spreading the MTS diameter cannot be measured effectively using the bright-field 
microscopy technique used in Figure 19, therefore, we employ a more quantitative 
assessment of cell death. 
 
 
Figure 24:  MTS structural integrity after photothermal therapy. After 40 W/cm
2
 
irradiation we see that the MTS are destroyed and lose structural integrity 
for both 24 hour and co-incubated GNRs. 
4.4.5 Quantitative Analysis of Cell Death Pathways 
After laser irradiation and cell death pathway staining, we performed quantitative 
analysis on the cells using flow cytometry. The device recorded the apoptotic (YP) and 
necrotic (PI) stain intensity for all cells and we plotted the intensities against each other 
with apoptosis on the x-axis and necrosis on the y-axis (Figure 25). Cells that are alive 
have low amounts of YP or PI fluorescence. Apoptotic cells have only moderate YP 
fluorescence and necrotic cells have high YP and PI fluorescence. To separate out the 
different regions of live, apoptotic and necrotic cells we performed control experiments. 
In Figure 25B, as a positive control we induced necrosis by using a cell lysis buffer to 
find the region of necrotic cell death, which indicates ~96% cell necrosis. As another 
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positive control (Figure 25C), we induced apoptotic cell death by exposing the MTS to 
ultraviolet light for one hour and let the MTS incubate for an hour before staining. In this 
control, the cells are evenly distributed between live, necrotic and apoptotic. Therefore, 
using this data we were able to define the appropriate regions for live, apoptotic and 
necrotic cells. In Figure 25A, we show the stained MTS negative control with no GNR or 
laser exposure, which has ~28% necrotic cell death, ~1.2% apoptotic cell death and 
primarily ~66% of the cells are live based on the determined regions. In Figure 25D, we 
show a representative sample of MTS with 24 hour incubated GNRs exposed to 40 
W/cm
2
 laser irradiation. In this case, the live cell percentage is 37.7% and the cell death 
was divided between 44.4% necrotic and 14.3% apoptotic cell death. 
After determining the regions to divide live, necrotic, and apoptotic cells, we 
quantitatively analyzed the respective percentages (with standard error over four 
replicates for each sample) for a fluence rate range (30-50 W/cm
2
) for both GNR delivery 
techniques (Figure 26). The 24 hour incubated GNR (Figure 26A) live cell percentage 
decreases with increasing fluence rate as expected. The necrotic cell percentage increases 
significantly between 30 and 35 W/cm
2
 laser irradiation, which can be designated the 
necrotic threshold. From there the necrotic percentage continues increasing at increasing 
fluence rates, yet at a smaller slope. The apoptotic percentage increases to a maximum 
(~13%) at 35 W/cm
2
 but decreases afterwards as necrosis becomes the dominant cell 
death pathway at higher fluence rates due to the larger temperature increases. 
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Figure 25:  Flow Cytometry region determination. Log-log plot of fluorescence 
intensity, apoptosis stain (YP) on the x-axis and necrosis stain (PI) on the y-
axis, (A) shows the negative control of only the MTS stained. (B) shows the 
necrotic positive control to determine the necrotic region. (C) shows the 
apoptotic positive control to determine the live, apoptotic and necrotic 
regions. (D) Representative sample of MTS incubated with GNRs for 24 
hours and exposed to 40 W/cm
2
 irradiation. 
We observed similar trends with MTS contained co-incubated GNRs (Figure 
26B). However, the necrotic cell death percentage increased significantly at a higher 
fluence rate, between 35 and 40 W/cm
2
, than the MTS incubated with GNRs for 24 hours 
(Figure 26C). Although, from 40 to 50 W/cm
2
 the necrotic cell death percentages 
increased at a steeper slope than the 24 hour GNR delivery method, most likely due to the 
differences in the distribution. The co-incubated GNR apoptotic percentages followed the 
same trend as the 24 hour incubated GNRs (Figure 26D), increasing till it reached a 
maximum (~16%) at 40 W/cm
2
 and decreased afterwards. Additionally, the apoptotic 
percentage for co-incubated GNRs did not decrease as dramatically as the MTS with 24 
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hour incubated GNRs. Interestingly, both the maximum necrotic and apoptotic cell death 
percentages were higher for the MTS damaged by co-incubated GNRs than 24 hour 
incubated GNRs (Figure 26C and D), suggesting that the cell death pathway response is 
dependent on the GNR location in the MTS. 
 
 
Figure 26:  Quantitative Analysis of Cell Death Response to Photothermal Therapy. In 
(A) and (B) we see the 24 hour incubated and co-incubated GNRs, 
respectively, with the live, necrotic and apoptotic percentages for several 
fluence rates and see the trends. In (C) and (D) we see the necrotic and 
apoptotic cell percentages respectively with both GNR delivery techniques 
compared together at several fluence rates. 
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4.5 DISCUSSION 
4.5.1 Multicellular Tumor Spheroid Growth Curve 
Understanding the MTS growth curve allowed us to choose the optimal 
experimentation time. We found that the MTS grew in 96 well plates to similar sizes due 
to the initial cell concentration incubated and the same growth environment for repeatable 
experimentation. The first growth region is the exponential growth region, in which the 
MTS has not fully formed a dense structure, which it achieves around day 3 (Figure 19). 
Due to small size and ability of nutrients to reach all cells in the MTS the growth is 
exponential until approximately day 5. The linear region indicates that there is the 
beginning of necrotic core formation as the MTS gets larger and the nutrients from the 
FBS and media cannot penetrate deep into the MTS. We chose day 6 after incubation 
(Figure 19) due to it best mimicking in vivo tumors in the early linear growth region. At 
that size, the MTS is denser and starts forming a necrotic core, which is necessary to 
effectively model our assessments as GNR penetration and photothermal therapy in an in 
vivo colon cancer tumor (130). The plateau region has no net growth and, thus, is not a 
good representation of in vivo tumors.  
4.5.2 Gold Nanorod Penetration in Multicellular Tumor Spheroids 
After determining the optimal day for experimentation, we performed penetration 
experiments to understand the GNR uptake kinetics in 3D cell structures. As shown from 
Figure 18, GNRs were synthesized to be utilized for the imaging and photothermal 
therapy of MTS. The NIR SPR plasmon peak was exploited for luminescence imaging 
with TPM. We chose two methods for GNR delivery in the MTS to create different 
distributions for comparison purposes. The GNRs incubated for 24 hours mimicked the in 
vivo circumstances by allowing the GNRs to penetrate into the MTS from the outside. 
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This technique is similar to GNR intravenous injections because the GNRs would flow 
through the blood vessels and due to the EPR phenomenon would extravasate and 
penetrate into the tumor. In vivo studies have shown that gold nanoparticles, in the tumor, 
seem mostly be located around the blood vessels, not penetrating much further (92, 93). 
We found a similar limited penetration in the GNR distribution as shown in Figure 21 
and Figure 22, with the GNRs only found in the outer ring, approximately ~20% of the 
radius into the MTS. As discussed previously, there are three growth regions within the 
MTS: (1) the outer proliferating area (~15% radially), (2) the middle quiescent area (~15-
60% radially), and (3) the necrotic core (60-100% radially) (159). Thus, the 24 hour 
incubated GNRs are only found in the outer proliferating region. This indicates that since 
it is less dense and continuously growing, GNRs can transport through that region, 
however, the GNRs seem to be unable to penetrate through to the higher density 
quiescent region.  
The other GNR delivery technique involved co-incubating the MTS with the 
GNRs. The GNRs were incubated simultaneously with the cells into the well at the same 
initial concentration as the 24 hour incubated GNRs. On the 6
th
 day of growth, with TPM, 
we found that the GNR distribution was significantly different than the 24 hour incubated 
GNRs (Figure 21 and Figure 22). The GNRs were distributed almost uniformly 
throughout the MTS with a slightly larger density in the outer ring. The GNRs are 
distributed throughout because the MTS appears to have grown around the GNRs and as 
the MTS grew larger the GNRs moved further outwards as well to the less dense MTS 
areas with some caught in the ECM. This ideal distribution is the current goal of all drug 
delivery studies but has not been able to be achieved in practice using oral or intravenous 
delivery. Even though this distribution is not relevant for comparing to in vivo results, we 
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believe it is important to study to show the photothermal therapeutic effects with the ideal 
situation of GNRs being distributed throughout the MTS.  
4.5.3 Gold Nanorod Localization in Multicellular Tumor Spheroids 
Using a higher magnification objective, we probed the GNR localization on the 
cellular level. As discussed in the GNR synthesis section, CTAB is present on the GNR 
surface. CTAB is a cationic surfactant, which allows for strong attraction to negatively-
charged cells as well as internalization due to the lipophilic cell membrane. As discussed 
in the earlier in vitro 2D monolayer experiments, the CTAB encourages cell 
internalization and possibly organelle localization within the cell. In 3D cell structures 
the positive GNR surface charge does not allow for deep MTS penetration due to the cell 
and ECM negative charge (165). However, due to the stacked and dense cell structure in 
the MTS, the cellular GNR localization is not a trivial process. Figure 23 shows the co-
incubated and 24 hour incubated GNRs within the center and periphery of the MTS, 
respectively. The co-incubated GNRs appear to be more aggregated but spread out 
through the MTS. However, possibly due to this aggregation and resulting size increase 
as well as the ECM negative charge, the GNRs were primarily shown to be in the ECM 
between the cells. Yet, some GNRs succeeded in cellular internalization as shown in 
Figure 23B. For the 24 hour incubated GNRs, the distribution between extracellularly and 
intracellularly located GNRs seems closer to even. Possibly due to the incubation time 
and limited GNR aggregation, we demonstrate the 24 hour incubated GNRs were able to 
internalize at a higher rate in the cells than the co-incubated GNRs. 
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4.5.4 Gold Nanorod-Mediated Photothermal Therapy of Multicellular Tumor 
Spheroids 
After determining the GNR penetration and uptake in the MTS, we performed 
photothermal therapy to destroy the MTS by inducing cell death. In our first experiments, 
we visually inspected the MTS structural integrity to determine whether cell death 
occurred (Figure 24). It is clearly seen that the MTS at 40 W/cm
2 
laser fluence rate lost 
all integrity and the cells were dislodged from the MTS and likely dead. However, such a 
qualitative method of utilizing bright-field imaging to examine structural integrity did not 
show any differences between the two GNR delivery methods.  
4.5.5 Quantitative Analysis of Cell Death Pathways 
To better understand the differences and the cell death pathway response to GNR-
mediated photothermal therapy we performed a quantitative assessment using a cell death 
pathway stain and flow cytometry. After determining the effective regions of live, 
necrotic and apoptotic cells by utilizing the relative stain intensity amounts detected 
(Figure 25), we analyzed 4 replicates of each MTS sample with the two GNR delivery 
methods and a range of fluence rates. In Figure 26, we observe that the 24 hour incubated 
GNRs have a large increase in necrotic cell death, from ~29% to 46%, at a lower fluence 
rate (35 W/cm
2
) than co-incubated GNRs (40 W/cm
2
) has the first large increase in 
necrotic cell death, from ~29% to ~49% (Figure 26). This increase in necrotic cell death 
indicates the induction of significant cell death by photothermal therapy; as a result, we 
refer to this fluence rate as the necrotic threshold. We believe this threshold value is 
lower for the 24 hour incubated GNRs due to the limited GNR distribution. Since the 
GNRs are all within the outer region there could be a significant coupling effect 
increasing the GNR absorption efficiency, thus, increasing the amount of thermal energy 
delivered to the surroundings. Due to this increase in heat more cells were killed for the 
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24 hour incubated GNRs than the co-incubated GNRs at the same fluence rate (35 
W/cm
2
). However, as the fluence rates increased, the necrotic cell percentages were 
similar at 40 W/cm
2
 for both delivery methods and actually higher for the co-incubated 
GNRs at 45 and 50 W/cm
2
 (Figure 26C). We believe that the co-incubated GNRs induce 
more cell death after the respective necrotic threshold because of the more uniform 
distribution. Due to the GNRs being spread throughout the MTS, the localized thermal 
energy released from the GNRs can affect a greater number of cells.  
Apoptotic cell death followed a different trend (Figure 26D). The apoptotic cell 
death percentages increased to a maximum at a certain fluence rate, which was observed 
to be same as the necrotic threshold, and decreased after that fluence rate. We believe that 
apoptosis follows this trend because it can be commenced at lower temperatures than 
necrosis due to the initiation process and intracellular signaling that occurs during 
apoptosis. In necrosis, the primary method of inducing cell death is through heating to 
cause sufficient membrane lysis; however, with apoptosis the lower heating could still 
induce protein denaturation and mitochondrial or nuclear disruption, thus initiating the 
apoptotic pathway. Thus, as the fluence rate is increased and the thermal energy being 
delivered increases, necrosis appears to become the dominant cell death pathway since 
almost all cells are dying through membrane lysis. For the 24 hour incubated GNRs, the 
fluence rate at which we see the maximum apoptosis (~13% at 35 W/cm
2
) is lower than 
for the co-incubated GNRs (16% at 40 W/cm
2
). The reasoning behind this, we believe, is 
similar to the necrotic threshold difference, which is the tightly localized area of the 24 
hour incubated GNRs induces slightly higher heating due to a possible coupling effect 
reaching the temperature needed to induce apoptosis at a lower fluence rate than co-
incubated GNRs. Conversely, the maximum apoptosis percentages for the co-incubated 
GNRs was detected to be higher than the 24 hour incubated GNRs, which we again 
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believe is because of the more uniform GNR distribution with the co-incubated GNRs 
delivering thermal energy to more cells. As the fluence rate increased the maximum 
necrotic percentages reached values of ~62% and ~75% for 24 hour incubation and co-
incubated respectively, which were ~2.9 and ~3.5 times the control necrosis values. The 
absolute maximum apoptosis percentages, on the other hand, were much smaller in 
comparison to the absolute maximum necrotic percentages. However, the percentages 
were determined to be ~3.8 and ~4.6, respectively, times the control apoptosis 
percentages. Therefore, with respect to the control, apoptosis is determined to be 
increased at a higher rate than necrosis in MTS exposed to photothermal therapy utilizing 
both GNR delivery techniques. 
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Chapter 5: Conclusions 
5.1 2D MONOLAYER PHOTOTHERMAL THERAPY 
In this study, we successfully targeted GNRs to different cell regions based on 
incubation time due to the time-dependent internalization process. Using TPM, we 
observed that GNRs were membrane-bound at 1.5 hours incubation time, starting to be 
internalized in lysosomal compartments at the 6 hour time point, and localized to 
organelles, hypothesized to be in the perinuclear space, at the 24 hour time point.  At 
each time point, we performed photothermal therapy on colon cancer cells incubated with 
GNRs to quantitatively determine the cell death response to highly localized GNR 
heating using flow cytometry. We found that the 1.5 hour time point required the highest 
fluence rate to induce necrosis and apoptosis while the 24 hour time point needed the 
lowest fluence rate for both. In addition, photothermal therapy at the 24 time point, 
comprised of internalized GNRs localized to organelles in the perinuclear space, resulted 
in the highest apoptotic percentage (~18.5%) while the 6 hour time point (~13%) and 1.5 
hour time points (9.2%) were less. Furthermore, the 24 hour and 6 hour time points had 
similar apoptosis values as other anti-cancer therapeutics. In conclusion, we believe this 
data indicates that the cell death pathway response to photothermal therapy is influenced 
by GNR localization, which we can utilize to optimize the process of photothermal 
therapy. 
5.2 3D MULTICELLULAR TUMOR SPHEROID PHOTOTHERMAL THERAPY 
In this portion of the study, we quantitatively analyzed the cell death pathway 
response to the GNR-mediated photothermal therapy in 3D cell cultures. The MCTS was 
shown to be an effective in vitro tumor model to understand how photothermal therapy 
affects the cell death pathways in vivo. Using two GNR delivery methods, we were able 
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to confirm two different distributions with TPM: (1) 24 hour incubated GNRs localized 
around the MTS periphery similar to in vivo studies and (2) co-incubated GNRs found 
spread almost uniformly throughout the MTS. With these two distributions, we explored 
the cellular response to photothermal therapy by measuring the apoptosis and necrosis 
values quantitatively with flow cytometry. We found that the using photothermal therapy 
we were able to induce necrosis and apoptosis at different fluence rates. As demonstrated 
there was a lower threshold for cell death, both apoptosis and necrosis, for the 24 hour 
incubated GNRs due to the tighter GNR distribution within the outer MTS ring leading to 
a possible coupling effect, enhancing GNR absorption. Conversely, the co-incubated 
GNRs had a higher maximum apoptotic and necrotic percentage values than the 24 hour 
incubated GNRs due to the uniform distribution allowing for more cells to be exposed to 
the thermal energy delivered from the GNRs. Through a quantitative assessment of the 
cell death response to photothermal therapy we gain a better understanding of the affect 
localized heating has on tumors. In conclusion, the fluence rates, 35 and 40 W/cm
2
 for 24 
hour incubated and co-incubated GNRs, respectively, at which apoptosis is at a maximum 
is preferable for the optimization of GNR-mediated photothermal therapy. 
5.3 COMPARISON OF CELL DEATH RESPONSE IN 2D AND 3D TO RELEVANT WORK 
Several studies have examined the effect of thermal therapy on cell death, 
specifically comparing the cell death pathway response to temperature. Thermal therapy, 
essentially, involves the bulk heating of tumor tissue using radio frequency or microwave 
radiation (166). As discussed in Chapter 1, the heating is not localized solely to the tumor 
and the temperature will be elevated in surrounding tissues as well leading to collateral 
damage. With thermal therapy, the temperature is elevated slightly above physiological 
levels, 43-50°C, for long time durations, 0.5-8 hours, to induce the cytotoxic response 
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(167). The temperature needs to be in that range due to the lack of localization and 
possible collateral damage, which is the reasoning for using GNR-mediated photothermal 
therapy with more selective heating. To measure temperature in our earlier studies, an IR 
camera was used. However, IR measurements only allow us to probe surface (~100 µm) 
averaged heating due to the lateral resolution and interference due to strong infrared 
absorption by water. In our later studies, we did not measure temperature during heating 
due to the difficulty of determining the temperature on the nanoscale and getting an 
accurate measurement of the MTS in depth. Therefore, a comparison with relevant 
previous results in thermal therapy using bulk heating may allow for some speculation on 
elevated temperatures achieved during GNR-mediated photothermal therapy. 
 One study performed whole body hyperthermia, 41.5°C for 2 hours, on mice with 
colon cancer and fibrosarcoma tumors (168). Cell death quantification was performed by 
histopathology on the tumor samples and grading apoptosis as ‘none’, ‘modest’, ‘mild’, 
‘moderate’ and ‘severe’ using cell morphology. The authors found that apoptosis 
increased and reached a maxima of ~43% apoptotic cell death 8 hours after hyperthermic 
treatment and the fibrosarcoma reached ~19% apoptotic cell death 4 hours after 
hyperthermia. 
Another study performed thermal therapy on ex vivo tumor slices (AT-1 Dunning 
prostate tumors) at several different temperatures and times (169). The authors also 
quantified apoptosis as ‘none’, ‘mild’, ‘moderate’ and ‘marked’ using histopathology 
visually inspecting the cell morphology, and karyorrhexic nuclear debris. The number of 
tissues that exhibited ‘moderate’ and ‘marked’ apoptosis was reported as a percentage of 
total tissues graded at 3, 24 and 72 hours after treatment. The treatments varied from 
40°C for 15 minutes to 70°C for 1 minute. The authors found that only at 40°C for 15 
minutes was there any significant degree of apoptosis characterized as ‘moderate’ or 
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‘marked’, however, it was not significant from the control. Furthermore, the authors 
established that apoptosis measurements were time-dependent and that at 24 and 72 hours 
after treatment apoptosis values were significantly higher than at the 3 hour time point. 
At higher temperatures (and shorter time durations), the authors observed no 
significant apoptosis, but still saw significant cell death, suggesting that it reached a 
threshold at which necrosis was the dominant cell death pathway. This finding is similar 
to our result that there is a threshold, either temperature or laser fluence rate (which are 
related), at which apoptosis decreases and necrosis becomes the primary method of cell 
death. Another study confirmed this same result finding moderate apoptotic values with 
treatment ranging from 42-45°C for 30 minutes, but above 45°C all cell death was 
through necrosis (170). In fact, this study showed that the apoptotic cell death 
percentages increased with as the temperature increased from 42 to 44°C (at which we 
see a maxima of ~55% apoptosis) and decreases as necrosis becomes the dominant cell 
death pathway, very similar to our findings. 
From the same group as the previous study, the authors performed thermal 
therapy at 43°C and 45°C for 30 minutes heating duration (171). Then they quantified 
apoptosis by histopathology similar as the other studies using morphology at 4, 6 and 8 
hours after treatment. In murine cancer cells, the authors measured from 1-20% apoptosis 
4 hours after 43°C treatment and 10-25% apoptosis (and one at 53%) after 45°C 
treatment. With most human cancer cells (carcinoma and melanoma), which is more 
relevant for our work, the authors observed ~ 20% apoptosis 6-8 hours after 43°C 
treatment. However, two types of Burkitt’s lymphoma (BM 13674 and WW2) had 95% 
and 97% apoptosis 8 and 6 hours, respectively, after 43°C treatment.  
Based on these results, we notice that the induction of cell death pathways directly 
depends on the cancer cell type, thus, making comparisons between different cell types is 
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difficult. In addition, all of these studies utilized bulk heating over long time durations at 
low temperatures, due to the non-specificity, which increases the difficulty in 
comparison. Furthermore, the quantitative measurements to determine apoptosis are 
dramatically different from our study and these older studies. In their study, the 
quantification was performed through histopathology, which is the gold standard, but is 
still subjective and only can look at a smaller sample size. Whereas, in our study, we 
performed flow cytometry, which still has some subjectivity in terms of determining the 
apoptotic region, but incorporates the whole sample. However, we can infer that our 
results with ~18% maximum apoptosis in monolayers and 16% maximum apoptosis in 
MTS are similar to some of the percentages seen in thermal therapy studies. For the first 
study explored, the authors inspected ~19% apoptosis in fibrosarcoma after 41.5°C for 2 
hours with whole body hyperthermia. In the other studies, the authors observed ~20% 
apoptosis after 43°C for 30 minutes in tissue slices and in vitro with their cancer cell 
types. As a result, we can speculate that in our studies when we achieved ~16-18% 
apoptosis, the temperatures inside the cells and MTS, respectively, were equivalent to 
43°C bulk heating for 30 minutes. However, to better understand the relationship 
between cell death pathways and heating during GNR-mediated photothermal therapy, 
future studies need to be performed in which temperature is accurately measured, 
possibly using magnetic resonance thermography, or GNR heating modeled, which has 
not been performed effectively yet. 
5.4 COMPARISON BETWEEN CELL DEATH RESPONSE FOR 2D AND 3D CELL CULTURE 
With quantitative results for cell death pathway response to 2D monolayer and 3D 
MCTS to GNR-mediated photothermal therapy, we can compare the trends. Figure 27 
shows the % necrotic or apoptotic cell death normalized by their respective negative 
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control, % necrotic or apoptotic cell death. The overall trends are the same for both 2D 
and 3D cell culture. The necrotic cell death percentage increases with increasing fluence 
rate for both the monolayer and MTS. In addition for both cell culture types, the 
apoptotic cell death percentage increased to a maximum and then decreased back down 
as the fluence rate increased.  
If we compare the necrotic percentages normalized with their respective controls 
between the two cell culture types, it is clear that there is a significantly higher amount of 
necrosis in 2D cell culture (up to 18  for 24 hour GNR incubation) than MTS (up to 3.5  
for co-incubated GNRs and 24 hour GNR incubation). Although, the initial necrotic cell 
death percentages for the control are very different between the 2D (~4.6%) and the 3D 
(~21.3%) due to the necrotic core in the MTS, which creates difficultly in comparing the 
response to the two different cell culture types. Yet in this case, there is significantly 
more absolute necrotic cell death in the 2D cell culture (~87%) for the 24 hour incubated 
GNRs than the MTS with either the co-incubated (~74%) or 24 hour incubated GNRs 
(62%) (p < 0.01). 
The absolute apoptotic cell death percentages follow a similar trend. The MTS 
cell culture had a significantly lower absolute apoptotic percentage (maximum of ~16% 
for co-incubated GNRs) than the 2D monolayer (maximum of ~18% for 24 hour 
incubated GNRs) (p < 0.05). However, the percentages normalized to the control 
illustrate an opposite result. In Figure 27, we observe that the monolayer 24 hour 
incubated GNRs (2.9 ) has a lower normalized value than either the 3D MTS co-
incubated (4.6 ) and 24 hour incubated GNRs (3.8 ). Similar to the normalized necrotic 
cell death difference, this disparity is due primarily to the apoptotic control percentages 
for 2D monolayer (~6.3%) and 3D MTS (3.5%). 
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Figure 27:  Comparison between apoptotic and necrotic cell percentages for 2D and 3D 
cell cultures. In this figure, all of the values in the plots are normalized by 
their respective controls to better allow comparisons between the 2D and 3D 
necrotic and apoptotic values. 2D has a larger normalized necrotic value 
than 3D but a lower normalized apoptotic value than 2D. 
Therefore, we notice that overall 3D cell culture has significantly less cell death, 
both apoptotic and necrotic, than the 2D monolayer for similar fluence rates and GNR 
incubation times, which is similar to what other studies have observed (158, 172). We 
believe this can primarily be attributed to GNR distribution and localization. For the 2D 
monolayer study, the GNRs are distributed throughout the monolayer and are most likely 
internalized in the perinuclear region of every cell for the 24 hour incubated GNRs. 
Whereas, in the 3D MTS, with the 24 hour incubated GNRs we determined that the 
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GNRs were only located in the outer ring (~20% of the radius) and with the co-incubated 
GNRs, even though the GNRs are distributed more evenly than the 24 hour incubated 
GNRs, it is still not feasible for GNRs to be beside or within every cell in the MTS. 
Furthermore, the tumor mimicking morphology, including the cell-cell and cell-ECM 
interactions found in the 3D MTS cell culture could prevent apoptotic and necrotic cell 
death from occurring. We believe that these interactions reduce toxicity in MTS not only 
because of the ECM formation mechanically resisting GNR penetration, but also possibly 
due to the inherent enhanced cellular function and repair ability in 3D cell structures 
allowing the cells to have a higher threshold for injury.  
5.5 FUTURE WORK 
All of this work completed in this dissertation was on the cellular level, 
understanding the mechanisms of cell death response to photothermal therapy based on 
the pathways involved, necrosis or apoptosis. Yet, as discussed in Chapter 1, there are 
other possible programmed cell death pathways that could be involved, such as 
pyroptosis and necroptosis. Therefore, in continuing studies, it would be of great 
importance to further differentiate the quantification of cell death pathways into all the 
possibilities. With the current fluorescent stains used in this study, we would be unable to 
differentiate between necrosis, pyroptosis and necroptosis because all involve cell lysis, 
which is how the PI stain internalizes into the cell. To understand the process, we could 
perform a time-dependent study to inspect when PI enters the cell since necrosis should 
be instantaneous during cell injury, pyroptosis is known to be rapid, and necroptosis 
should be on the same time scales as apoptosis. A better differentiation would involve 
utilizing potential biomarkers, such as necrostatins for necroptosis, for each cell death 
type, which would need to be explored more extensively (111). 
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Furthermore, in future work, it would be extremely valuable to understand the 
processes, now that we confirmed differences based on GNR localization, on the 
molecular level. This includes gaining a better understanding of the effect of heating on 
the protein structures and probing macromolecular transitions and caspase activation with 
regards to apoptotic cell death. As discussed in the introduction, both initiator and 
executioner caspases are vital in the initiation and continuation of the apoptotic pathway. 
Therefore, probing the caspase activity will provide a better indication of the apoptotic 
processes occurring, especially if, as is usually the case with cancer, the apoptotic 
pathway is suppressed either upstream or downstream of the caspase activation. 
Therefore, to get an accurate understanding of the processes occurring on the molecular 
level, we would need to probe the apoptotic pathway at several different levels to 
determine where the suppression was located. 
If any three of the primary macromolecules (nucleic acid inactivation, protein 
denaturation, and lipid transitions) undergo significant transitions, cell death can be 
initiated in the form of apoptosis or necrosis.  Nucleic acids (DNA/RNA) encode, 
transmit and express all cellular genetic material and protein synthesis.  The inactivation 
transition of nucleic acids through heat is known to occur at ~85-90°C, which is 
significantly higher than the hyperthermic regime.  Studies have shown that it is not 
possible to affect DNA/RNA directly using solely hyperthermic heat shock (173).  The 
boundary membranes for all significant intracellular organelles as well as the outer 
membrane of the cell are composed of lipids, mediating intracellular homeostasis by 
trafficking membrane transport.  Lipids have not been shown to melt, transitioning from a 
solid to a liquid, at temperatures greater than 37°C (during heat shock), which would 
remove the barrier to intracellular transport (174, 175).  Studies have shown that 
hyperthermic heat shock affects the lipid membranes slightly, resulting in changes in the 
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intracellular concentrations of certain ions (Ca
2+
 for example); however, it has been 
shown that this does not adversely affect cell survival (176-178).  Proteins perform all 
basic functions in the cell, strongly utilized in the signal transduction and cell death 
pathways.  The denaturation transition of proteins has similar activation energies to cell 
death caused by thermal therapy (6, 179).  Differential scanning calorimetry (DSC) 
studies performed on cells show that significant transitions occur in the hyperthermic 
regime (>43°C), which were shown to be intracellular protein denaturation (180).  
Utilizing ethanol, which sensitizes proteins to denaturation, and glycerol, which protects 
proteins from denaturation, elicited expected results for those transitions, further 
suggesting that the transition is protein denaturation. 
Furthermore, we could also look at the response to photothermal therapy in terms 
of heat shock and cellular resilience and repair function. Inactivation is not the only result 
of thermal therapy, some protein pathways are activated due to heat shock. Cells can 
develop thermotolerance through the activation of the heat shock proteins (HSP).  When 
cells are exposed to high temperatures for short time periods or lower temperatures for 
long durations, HSP synthesis is instigated.  There are many different forms of HSPs 
based on their size (kDa), from small (<40 kDa), to HSP60, HSP70, HSP90 and HSP100 
families.  Many of these HSPs function as protein chaperones and prevent apoptosis due 
to any forms of stress, including heat (181, 182).   
HSPs protect newly formed proteins and older, denatured proteins by preventing 
aggregation that would result in loss of function, allowing enough time for the protein to 
refold properly (183).  Furthermore, many HSPs inhibit molecules that that are integral to 
the apoptotic pathway.  For example, HSP27 inhibits cytochrome C, whereas HSP70 and 
HSP90 inhibit the formation of the apoptosome and intervene in the caspase pathway.  
Nevertheless, when cells are exposed to higher temperatures at sufficient durations HSPs 
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cannot be synthesized to prevent apoptosis.  Relevant to this study, HSP formation can be 
used as an indicator of protein denaturation as well as the initiation of the apoptotic 
cascade.  Studies have analyzed HSP activation as a method to evaluate the cell reaction 
to thermal therapy (184). 
In addition, we can explore other parameters to gain a better understanding, such 
as the length of laser irradiation time. Essentially, we would try to determine if we reduce 
the fluence rate and increased the exposure time, would the apoptotic pathway (or 
specific macromolecular transitions) be initiated more significantly. Ideally, these 
modifications could be tested with a finite element model based on the heat equation and 
a system of state equations describing the different possible cellular responses (185). 
5.6 FINAL CONCLUSIONS 
Overall in this study we observed and quantified the cell death pathway response 
to GNR-mediated photothermal therapy in 2D and 3D cell structures. Therefore, we have 
indicated that threshold for cell death and, more specifically, the cell death pathways 
initiated are affected by GNR localization on the cellular level in 2D. Furthermore, with 
the 3D cell structure we found that GNR distribution made a significant difference in cell 
death pathway response. We also determined that there is less overall cell death, both 
apoptotic and necrotic, due to photothermal therapy in the 3D MTS than in the 2D 
monolayer study. Consequently, we believe these differences between cell death pathway 
response to GNR-mediated photothermal therapy in 2D and 3D cell culture lends 
credence to the belief that a 3D in vitro tumor structure, like MTS, are necessary to 
accurately model the findings that would be seen in an in vivo tumor. We believe using 
3D MTS provides significant benefits over 2D monolayer studies for toxicity 
calculations, such as GNR-mediated photothermal therapy. In conclusion, we believe that 
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these MTS allow for accurate assessments of the GNR penetration and distribution 
through an ECM and densely packed cell structure as well as providing a better 
evaluation of the cell death pathway response to cancer therapeutics, such as 
photothermal therapy, due to cell-cell and cell-ECM interactions augmenting the cellular 
resilience through increased cell repair function. Through the cell death pathway response 
quantification for gold nanoparticle-mediated photothermal therapy we gain a better 
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